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Development and Characterization of Novel Ras Inhibitors 
LaKiesha S. DeBose, B.S. 
Supervisory Professor: John F. Hancock, Ph.D. 
Ras genes are mutated in 15% of human cancers.  Ras GTPases operate as 
molecular switches regulating cellular processes including proliferation, 
differentiation, and apoptosis.  The three main isoforms of Ras – H-Ras, K-Ras, and 
N-Ras – inhabit distinct nanodomains of the plasma membrane and intracellular 
compartments including the Golgi.  However, the role of single endogenous Ras 
isoforms on these compartments remains unclear as most studies have utilized 
ectopically expressed and mutant forms of Ras proteins.  In an effort to develop 
novel tools that will allow us to abrogate individual endogenous Ras isoforms, we 
targeted the catalytic domain of p120RasGAP to the plasma membrane with the 
hypervariable region (HVR) of H-Ras (GAP-CTH) or K-Ras (GAP-CTK) and to the 
Golgi using the HVR of H-Ras with insertion of a point mutation (GAP-CTH181S).  
We performed GST-RBD pull-downs on cells expressing each GAP construct and 
stimulated with epidermal growth factor (EGF).  We found that GAP-CTH and GAP-
CTK specifically inhibited H-Ras or K-Ras, respectively.  However, we did not detect 
any effect of GAP-CTH181S on Ras activation.  Additionally, we used confocal 
microscopy to verify the ability of GAP constructs to abrogate Ras activation in 
distinct sub-cellular compartments.    We found that GAP-CTH inhibits H-Ras 
activation on the plasma membrane, while GAP-CTK inhibits K-Ras activation on 
the plasma membrane.  On the contrary, GAP-CTH181S inhibited H-Ras activation 
on the Golgi.  We also analyzed the effects of these GAP constructs on the 
activation of ERK and Akt in response to EGF stimulation.  We found that EGF 
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stimulation of the MAPK pathway was inhibited by GAP-CTK but none of the other 
GAP constructs, while Akt activation was not inhibited by any GAP construct.  
Finally, we assayed cellular proliferation and differentiation.  We found that GAP-
CTK and GAP-CTH were equipotent inhibitors of cellular growth, whereas GAP-
CTH181S was less potent.  We also found that GAP-CTK and GAP-CTH inhibited 
differentiation with similar potency, while GAP-CTH181S was more potent.  This 
approach may be adapted to investigate any Ras-dependent signaling pathway.  
Therefore, it has the potential to become a powerful tool for studying Ras isoform-
specific signaling outputs. 
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1.1 Introduction 
Ras genes were originally identified as the oncogenes in the Harvey and 
Kirsten sarcoma retroviruses responsible for inducing tumors in rats.  These 
retroviral oncogenes were called ras, for rat sarcoma, and were later identified in 
mammalian cells as mutated versions of normal cellular ras genes.  Three ras 
proto-oncogenes exist in the human genome:  H-ras, K-ras, and N-ras (Malumbres 
and Barbacid, 2003; Prior et al., 2012). The latest gene, N-ras, was identified in 
neuroblastoma cells; however, has not been found in any retrovirus.  
Constitutively active ras mutations are present in 15% of human cancers.  
Point mutations in codons 12, 13, or 61 make ras oncogenic. There are other 
mutations that may convert ras into oncogenes such as codon 146 in K-ras.  These 
mutations lock Ras in the active state by rendering Ras resistant to the effects of 
GTPase activating proteins (Barbacid, 1987; Lau and Haigis, 2009).  
Each ras gene encodes a specific Ras isoform except K-ras, which bears two 
gene products (K-Ras 4A and K-Ras 4B) generated through alternative splicing 
(Capon et al., 1983; McGrath et al., 1983).  All Ras isoforms are expressed 
ubiquitously in cells except for K-Ras 4A which is restricted temporally and spatially 
to the lung, liver, and kidney (Pells et al., 1997).  Ras isoforms are highly 
homologous with nearly identical sequences in the effector, exchange factor, and 
guanine nucleotide binding domains (amino acids 1-165), which together comprise 
the G domain.  The C—terminal hypervariable region (amino acids 166-188/189) is 
the only region of Ras proteins that shows significant sequence divergence between 
the isoforms (Hancock and Parton, 2005).  
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Ras proteins are 21 kilodalton peripheral membrane GTPases that bind 
guanosine triphosphate (GTP) or guanosine diphosphate (GDP) to control signal 
transduction cascades.  Ras signaling regulates a variety of cellular functions  
 
 
Figure 1.1. Ras Molecular Switch.  At the plasma membrane, Ras proteins 
operate as a molecular switch oscillating between an inactive GDP-bound and an 
active GTP-bound conformation.  In response to an exogenous signal, RasGEFs 
are activated and promote the GTP binding of Ras.  Consequently, active Ras can 
interact with and activate downstream effector proteins.  The degree of Ras 
activation is tightly controlled by RasGAPs which greatly enhance the ability of Ras 
to hydrolyze GTP to GDP. 
 
including proliferation, differentiation, and survival.  Two sets of proteins, guanine 
nucleotide exchange factors (GEFs) and GTPase activating proteins (GAPs) 
modulate Ras activity.  GEFs stimulate the exchange of GDP for GTP.  Ras in the 
GTP-bound state is active (Bos et al., 2007; Satoh and Kaziro, 1992); GTP-loading 
triggers a conformational change in the Switch 1 (amino acids 30-38) and Switch 2 
(amino acids 60-76) regions in the G domain endowing Ras proteins with a high 
affinity for downstream effectors (Wittinghofer et al., 1993).  In contrast, GAPs act 
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as negative regulators to greatly enhance the intrinsic GTPase activity of Ras to 
hydrolyze GTP to GDP rendering Ras inactive (Bos et al., 2007) .  
Ras is the founding member of a family containing a multitude of small 
GTPases that regulate signal transduction pathways.  The Ras superfamily is 
comprised of 5 subfamilies:  Arf, Rab, Ran, Rho, and Ras (Wennerberg et al., 
2005).  The Arf subfamily of proteins is involved in vesicular budding (Nie et al., 
2003), while the Rab subfamily is involved in vesicle targeting and fusion (Zerial and 
McBride, 2001).  The Rho subfamily is responsible for the control of cytoskeletal 
organization and cell motility (Etienne-Manneville and Hall, 2002).  Finally, Ran is 
involved in nucleocytoplasmic transport and cell cycle progression (Pemberton and 
Paschal, 2005; Weis, 2003). 
The Ras subfamily is subdivided into groups, which share 40-50% sequence 
homology with the classical Ras proteins.  The Ras protein subfamily includes the 
following:  Ras (H-Ras, N-Ras and K-Ras), R-ras proteins (R-ras, TC21, and M-
Ras), Rap proteins (Rap1A, Rap1B, Rap2A, and Rap2B), Rheb, and RalA and 
RalB.  The R-Ras subfamily of proteins regulates mitogenesis and the cytoskeleton 
and is mutated in some human tumors (Ehrhardt et al., 2002).  Rap proteins are 
involved in the control of cell adhesion and spreading mediated by integrin (Bos, 
2005; McLeod et al., 2004).  RalA and RalB proteins have various functions 
including regulation of cell morphology changes, cell motility, and the activity of 
transcription factors (Feig, 2003).  Rheb proteins are associated with the control of 
cell growth and the cell cycle (Aspuria and Tamanoi, 2004). 
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1.2 Ras Processing and Trafficking 
1.2.1 Post-translational Modification of the Hypervariable Region 
Ras proteins are synthesized as hydrophilic molecules in the cytosol and are 
posttranslationally modified by the attachment of a hydrophobic anchor for 
membrane association (Mor and Philips, 2006).  The C-terminal hypervariable 
region contains two signal sequences that are responsible for targeting Ras proteins 
to the cytoplasmic face of the plasma membrane.  The first of these sequences is 
the CAAX motif (C for cysteine, A for aliphatic amino acids, and X for any amino 
acid) located at the extreme C-terminus of the HVR (Hancock et al., 1989).  The 
CAAX motif undergoes a series of posttranslational modifications.  The first 
modification is prenylation of the cysteine by the cytosolic enzyme, protein 
farnesyltransferase, which is covalently attached (Hancock et al., 1990; Reiss et al., 
1990; Schaber et al., 1990).   Further modification of the CAAX motif occurs on the 
cytoplasmic face of the endoplasmic reticulum (Choy et al., 1999).  The AAX 
residue is cleaved by a protease called Ras converting enzyme 1 (Rce1) 
(Boyartchuk et al., 1997; Gutierrez et al., 1989). Finally, the now C-terminal 
farnesylated cysteine is methylated on the α-carboxyl group by 
isoprenylcysteinecarboxyl methyltransferase (Icmt) (Dai et al., 1998).  The CAAX 
motif of Ras proteins increases the hydrophobicity of the Ras C-terminus, but is 
insufficient for stable membrane binding.  A second membrane signal is required for 
targeting Ras to the plasma membrane (Hancock et al., 1990).  In H-Ras, K-Ras 4A 
and N-Ras, this signal is palmitoylation of one or two cysteines upstream of the 
CAAX motif by Ras palmitoyltransferase (RPT) (Lobo et al., 2002).  RPT is located 
on the ER and Golgi apparatus in mammalian cells (Apolloni et al., 2000; Chiu et 
al., 2002).  While H-ras has two sites for palmitoylation at C181 and C184, K-Ras 
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4A and N-Ras have one site at C180 and Ras and N-Ras.  The half-life of palmitate 
on H-Ras is 2.4h while the half-life of palmitate on N-Ras is only 20 min. (Baker et 
al., 2003; Lu and Hofmann, 1995).  In contrast to H- and N-Ras, K-Ras 4B has a 
polybasic region of six lysine residues responsible for plasma membrane 
association (Hancock et al., 1990).   
1.2.2 From the Endoplasmic Reticulum to the Plasma Membrane 
 Posttranslational modification of the C-terminal CAAX motif of nascent Ras 
proteins is completed on the membrane of the endoplasmic reticulum.  Further 
modification of H-Ras and N-Ras by RPT occurs upstream of the CAAX motif on the 
ER and the Golgi apparatus where H-Ras and N-Ras traffic to the plasma 
membrane via the secretory pathway, K-Ras is not palmitoylated and traffics to the 
plasma membrane by a route that is unclear; (Hancock, 2003; Swarthout et al., 
2005) however, mechanisms for K-Ras transport have been suggested.  One such 
mechanism is that the positively charged polybasic region of K-Ras contributes to 
diffusion of this isoform down an electrostatic gradient to the negatively charged 
lipid head groups on the plasma membrane (Okeley and Gelb, 2004; Roy et al., 
2000).  The final hypothesis is that K-Ras transport is dependent upon microtubules 
(Chen et al., 2000; Thissen et al., 1997). 
 1.2.3 From the Plasma Membrane to the Endomembrane 
 Recent studies have shown that Ras is not permanently anchored to the 
plasma membrane, but undergoes retrograde trafficking.  H-Ras and N-Ras engage 
in a continuous cycle of palmitoylation/depalmitoylation that maintains specific 
localization of these proteins to the plasma membrane and Golgi apparatus.   
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Figure 1.2. Processing and Intracellular Trafficking of Ras Proteins.  The 
extreme   C-terminal CAAX motif of Ras proteins is postranslationally modified in a 
series of steps that occur in the cytosol and on the surface of the endoplasmic 
reticulum (ER).  Next, H-Ras and N-Ras, traffic from the endomembrane to the 
plasma membrane via the classical exocytic pathway.  On the contrary, K-Ras exits 
the ER and is transported to the plasma membrane by an alternative pathway that 
is independent of the Golgi which has yet to be elucidated.  Also shown are the 
retrograde pathways for Ras isoforms transported from the plasma membrane to 
the endomembrane.  
 
Palmitoylated Ras proteins on the plasma membrane are depalmitoylated by an 
unidentified thioesterase causing them to be released from the cytoplasmic face of 
the plasma membrane where they diffuse through the cytosol to the Golgi 
membrane.  Non-palmitoylated H-Ras and N-Ras encounter RPT on the ER and 
Golgi and are repalmitoylated (Goodwin et al., 2005; Rocks et al., 2005).  After 
palmitoylation has occurred, Ras proteins traffic to the plasma membrane via 
vesicular transport (Apolloni et al., 2000).  In contrast, K-Ras does not undergo 
further lipid modification through palmitoylation, but also engages in retrograde 
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trafficking. In hippocampal neurons, activation of the glutamate receptor induces 
Ca2+ influx and the subsequent binding of calmodulin to the polybasic-prenyl motif 
of K-Ras.  This results in the dissociation of K-Ras from the plasma membrane and 
the redistribution of K-Ras to the Golgi apparatus and early/recycling endosomes 
(Fivaz and Meyer, 2005).  Like calmodulin, other protein chaperones including 
smgGDS, phosphodiesterase 6 delta subunit (PDEδ) and prenylated Rab protein 
acceptor protein 1 (PRA1) may be responsible for the transport of K-Ras away from 
the plasma membrane.  These protein chaperones stimulate the dissociation of K-
Ras and other small GTPases from the plasma membrane (Bhagatji et al., 2010; 
Kawamura et al., 1993).  Recent studies have emerged elucidating this role for 
PDEδ in the intracellular trafficking and signaling of Ras isoforms.  The current 
model for PDEδ-mediated Ras trafficking demonstrates the extraction of K-Ras and 
H-Ras from the (Bhagatji et al., 2010; Kawamura et al., 1993) endomembrane and 
plasma membrane, respectively.  PDEδ sequesters the farnesyl chain of Ras in a 
hydrophobic pocket resulting in the solubilization Ras in the cytosol.  Non-
prenylated small GTPases called Ar12/3 bind to PDEδ stimulating the release of 
Ras onto the plasma membrane (K-Ras) and Golgi (H-Ras) (Chandra et al., 2012; 
Ismail et al., 2011; Philips, 2012).  An alternative mechanism of K-Ras retrograde 
trafficking involves phosphorylation of K-Ras on serine 181 by protein kinase C 
neutralizing the negative charge of the polybasic domain (Bivona et al., 2006). 
Furthermore, K-Ras is in dynamic equilibrium with a pool in the cytosol (Mor and 
Philips, 2006).  
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1.3 Ras Guanine Nucleotide Exchange Factors  
1.3.1 Son of Sevenless (Sos) 
 Son of sevenless is a well-characterized cytosolic Ras guanine nucleotide 
exchange factor that is responsible for coupling intracellular signals from receptor 
tyrosine kinases to Ras proteins (Aronheim et al., 1994).  Sos1 and Sos2 are two 
isoforms that are ubiquitously expressed in mammalian cells (Chardin et al., 1993).  
Although these proteins are highly homologous, Sos2 has a higher binding affinity 
for Grb2 than Sos1 suggesting that these GEFs may differentially contribute to 
receptor-mediated Ras activation (Bowtell et al., 1992; Yang et al., 1995). The 
Cdc25 and Ras exchanger motif (REM) domains of Sos are required for Sos-
mediated Ras specific nucleotide exchange.  The REM domain connects with a 
surface of the Cdc25 domain. Ras interacts with Sos entirely through binding of the 
Cdc25 domain for nucleotide exchange.  The product of this exchange reaction, 
GTP-loaded Ras, interacts with a distal allosteric site on Sos that is between the 
Cdc25 and REM domains creating a bridge between these domains and enhancing 
Ras exchange activity.  This indicates that Sos is subject to positive feedback 
regulation by Ras-GTP (Margarit et al., 2003; Sondermann et al., 2004) .  The 
generally accepted model for how Sos activates Ras on the plasma membrane is as 
follows:  In response to extracellular stimuli, tyrosine kinase receptors are activated 
and undergo autophosophorylation at tyrosine residues.  In the cytosol, Sos is 
bound to Grb2 through the interaction of its carboxyl terminus proline-rich 
sequences and Src homology 3 domain of Grb2 (Buday and Downward, 1993; 
Egan et al., 1993; Li et al., 1993).  The Grb2-Sos complex translocates to the 
plasma membrane where the Src homology 3 domain of Grb2 associates with the 
phosphorylated residues of the receptor. Sos is brought into close proximity to Ras 
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on the plasma membrane and GDP/GTP exchange is catalyzed (Lowenstein et al., 
1992; Rozakis-Adcock et al., 1993).  This model has undergone review based on a 
recent study showing that a lipid-protein interaction with phosphatidic acid (PA) is, in 
fact,  
 
Figure 1.3. The Activation of Ras Proteins on the Plasma Membrane.  (A)  Ras 
isoforms are activated by the RasGEF Sos on the plasma membrane.  The process 
is initiated by the binding of a growth factor to a receptor tyrosine kinase (RTK) 
followed by autophosphorylation of specific tyrosine residues within the cytoplasmic 
tail of the receptor.  These events promote the translocation of Grb2/Sos 
heterodimers from the cytosol to the plasma membrane allowing Sos to stimulate 
the exchange of GDP for GTP on Ras, rendering Ras proteins active. (B) A recently 
discovered component of Ras activation by the EGF receptor on the plasma 
membrane is PLD2.  On the plasma membrane, phosphatidic acid (PA) produced 
by PLD2 recruits Sos, facilitating the activation of Ras. (C) Ras activation occurs 
downstream of the G-protein-coupled receptor (GPCR).  Heterotrimeric G-proteins 
are dissociated into Gα and Gβγ subunits following ligand binding of the GPCR.  
Then, the Gβγ subunit stimulates the recruitment of PI3Kγ to the plasma 
membrane, resulting in Src activation.  Tyrosine residues within the EGFR and Shc 
are phosphorylated by activated Src.  Shc then recruits Grb2/Sos complex to the 
plasma membrane resulting in the activation of Ras. 
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accountable for recruitment of Sos to the plasma membrane upon EGFR 
stimulation.  PA is generated by phospholipase D2 (PLD2) via the hydrolysis of 
phosphatidylcholine (PC) (Zhao et al., 2007). 
1.3.2 Ras Guanine-Nucleotide Release Factors (RasGRFs) 
 The RasGRF family of guanine-nucleotide exchange factors is comprised of 
two isoforms, RasGRF1 and RasGRF2.  The expression of these proteins is 
restricted to specific tissue locations.  Both isoforms are predominantly expressed in 
the brain.  Traces of RasGRFs expression have also been detected in the heart, 
lung, and pancreas.  The regulation of RasGRFs in signal transduction occurs in a 
different manner than Sos proteins.  RasGRF1 and RasGRF2 are activated in 
response to elevated levels of cytosolic calcium.  A signaling pathway involving 
activation of the N-methyl-d-aspartate (NMDA) receptor in neuronal cells by 
ionomycin is known to trigger calcium-dependent activation of RasGRFs.  This 
activation is mediated by binding of calmodulin to the IQ motif of RasGRFs, which 
stimulates the translocation of RasGRFs to the plasma membrane (Farnsworth et 
al., 1995).  Once at the plasma membrane RasGRFs stimulate Ras guanine 
nucleotide exchange.   Although ionomycin preferentially activates RasGRF1 at the 
plasma membrane, it also induces activation of RasGRF1 at the endoplasmic 
reticulum at lower levels.  RasGRF1 is also activated in response to ligand 
stimulation of the G-protein coupled receptor (GPCR).  Full activation of RasGRF1 
requires serine and tyrosine phosphorylation events and the release of calcium from 
intracellular stores in response to inositol-(1,4,5)-triphosphate (IP3) generated by 
GPCR-activated phospholipase C (Tian et al., 2004).  Non-receptor tyrosine kinases 
such as the Cdc42-associated kinase 1 (ACK1) and Src (sarcoma) have also been 
shown to phosphorylate RasGRF1 (Kiyono et al., 2000).   
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1.3.3 Ras Guanyl-Releasing Proteins (RasGRPs) 
 Another family of Ras guanine nucleotide exchange factors is the Ras 
guanyl-releasing proteins, RasGRP1, RasGRP2, RasGRP3, and RasGRP4 
 
 
Figure 1.4.  Activation of Ras by RasGRFs.  In neurons, stimulation of the N-
methyl-D-aspartate glutamate ligand-gated ion channel receptor (NMDAR) 
generates an influx of calcium (Ca2+).  Consequently, calmodulin (CaM) binds to the 
IQ domain of RasGRF.  This prompts the translocation of RasGRFs to the plasma 
membrane by an unidentified mechanism, resulting in activation of RasGRF.  
RasGRF activation also occurs downstream of the G-protein coupled receptor 
(GPCR).  Upon stimulation of the GPCR, phospholipase C (PLC) is activated 
causing the production of inositol-(1,4,5)-triphosphate (IP3) which in turn stimulates 
intracellular Ca2+ release, resulting in RasGRF activation.  Cdc42-associated kinase 
1 (ACK1) may contribute to RasGRF activation by phosphorylation. 
 
(Mitin et al., 2005).  Like RasGRFs, RasGRP proteins have a restricted pattern of 
expression.  RasGRP1 and 3 are predominantly expressed in the adult brain and 
lymphoid tissues with some expression present in the kidney (Ebinu et al., 1998; 
Tognon et al., 1998; Yamashita et al., 2000).  RasGRP2 is expressed in a wide 
range of tissues including the brain, heart, lungs, pancreas, and kidney (Clyde-
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Smith et al., 2000).  RasGRP4 is expressed in peripheral blood mononuclear 
leukocytes in adults, while fetal expression is distributed in the heart, lung, kidney, 
liver, and thymus (Yang et al., 2002).  In addition to the catalytic domains REM and 
CDC25 that all Ras guanine nucleotide exchange factors possess, RasGRPs 
contain calcium binding EF hands and diacylglycerol (DAG) binding C1 domains.  
The deletion of these domains results in the inability of RasGRP1 to activate Ras 
and transform fibroblasts.  The membrane recruitment and activation of RasGRPs1,  
 
 
Figure 1.5. Activation of Ras by RasGRPs.  Upon activation of the TCR, the 
scaffold protein LAT is phosphorylated by Zap70 which provides binding sites for 
the recruitment of PLC and the GRB2/Sos complex.  PLC then hydrolyzes PtdInsP2 
which in turn generates DAG and InsP3.  Calcium is released from intracellular 
stores by InsP3 recruiting the RasGAP CAPRI to the plasma membrane; therefore 
Ras activation by Sos is prevented.  At the same time, calcium along with DAG 
drive RasGRP1 to the Golgi, where H- and N-Ras are activated.  Co-activation of 
LFA-1 with the TCR results in increased levels of DAG through PLD2 and PAP.  
These DAG levels are sufficient to recruit RasGRP1 to the plasma membrane 
where Ras is activated. 
 
 
3, and 4 is directly dependent on DAG binding to their C1 domains (Ebinu et al., 
1998).  In contrast, RasGRP2 is constitutively associated with the membrane by N-
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terminal myristoyl and palmitate modifications, but its ability to stimulate nucleotide-
exchange on Ras is also enhanced by DAG.  DAG production is coupled to 
phospholipase C activity, which generates the second messengers, DAG and IP3 
(Clyde-Smith et al., 2000). Furthermore, RasGRP1 and RasGRP3 are the only 
RasGEFs that are localized in the Golgi apparatus (Caloca et al., 2003). 
1.4 Ras GTPase-Activating Proteins (RasGAPs) 
1.4.1 p120 RasGAP 
 p120 RasGAP was the first GTPase activating protein (GAP) to be 
discovered (Trahey and McCormick, 1987).  Inactivating mutations in the RASA1 
gene, which codes for p120GAP, are found in patients with a capillary malformation-
arteriovenous malformation syndrome (Eerola et al., 2003).  p120 RasGAP helped 
to elucidate the reason behind missense mutations at Ras residues G12 or Q61 that 
result in constitutively active Ras.  These Ras mutant proteins are insensitive to 
GAP activity and are trapped in the active GTP bound conformation.  p120 RasGAP 
interacts with Ras at the effector site (Der et al., 1986; Scheffzek et al., 1997; 
Seeburg et al., 1984).  The mechanism of p120 RasGAP-assisted GTP hydrolysis 
involves the stabilization of glutamine at position 61 of Ras by GAP.  An arginine 
provided by GAP is positioned into the phosphate-binding site and stabilizes the 
transition state by neutralizing the negative charge. Mutation of glutamine 61 
abolishes GAP-induced hydrolysis (Ahmadian et al., 1997; Coleman et al., 1994). 
p120 RasGAP is a widely expressed cytoplasmic protein that is comprised of 
several domains including a GAP catalytic domain and an N-terminal region 
containing two SH2 motifs, one SH3 motif, a pleckstrin homology domain, and the 
calcium dependent lipid binding motif, C2.  The two SH2 motifs are responsible for 
interactions with activated tyrosine kinase receptors and other tyrosine 
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phosphorylated proteins (Cleghon et al., 1998; Kaplan et al., 1990).  p120 RasGAP 
is also a caspase substrate.  When cleaved by caspases this protein negatively or 
positively regulates apoptosis in a manner that is dependent on caspase activation 
(Yang and Widmann, 2001). 
1.4.2 Neurofibromin 
 Neurofibromin is a large cytoplasmic protein encoded by NF1, a tumor 
suppressor gene that is lost in the autosomal dominant disease neurofibromatosis 
type 1 (Dasgupta and Gutmann, 2003).  Clinically, this disease is characterized by 
learning disabilities, bone deformities, nervous tumors, and gliomas.  Neurofibromin 
is expressed mostly in Schwann cells, neurons, astrocytes, leukocytes, and 
oligodendrocytes (Dasgupta and Gutmann, 2003; Jouhilahti et al., 2011).   
The known functional domains of neurofibromin are limited to the Sec14/PH 
module and the RasGAP catalytic domain. The Sec14/PH module lies at the C-
terminus of the catalytic domain and consists of a Sec 14 homology segment and a 
neighboring PH-like domain. The Sec 14 homology segment binds to 
glycerophospholids and mediates the exchange of phosphatidylinositol for 
phosphatidylcholine between membrane compartments, a common process 
associated with lipid metabolism and membrane trafficking.  Association of the PH-
like domain with the Sec-14 homology segment through an interface allows for 
regulation of phospholipid binding. A specific region of neurofibromin shares 
sequence homology with the RasGAP catalytic domain of p120 RasGAP referred to 
as the GAP related domain (GRD) (Trovo-Marqui and Tajara, 2006).  This domain 
has a higher affinity for H-Ras and N-Ras than p120 RasGAP. The RasGAP domain 
activity of neurofibromin is inhibited by three lipids:  arachidonate, phosphatidate, 
and phosphatidylinositol-4,5-biphosphate (Bollag and McCormick, 1991).  
16 
 
1.4.3 GAP1  
 GAP1 is another family of RasGAPs that includes two subgroups GAP1m and 
GAP1IP4BP,and Calcium promoted Ras inactivator (CAPRI) and Ras-GTPase-
activating-like protein (RASAL) (Lockyer et al., 1997; Yarwood et al., 2006).  Both 
GAP1m and GAP1IP4BPare ubiquitously expressed and are activated by binding of 
phosphoinositides to the pleckstrin homology domain found in both proteins 
(Lockyer et al., 1999).  GAP1IP4BPconstitutively associates with the plasma 
membrane (Lockyer et al., 1997) while GAP1m translocates from the cytosol to the 
plasma membrane in response to EGF stimulation (Lockyer et al., 1999).  CAPRI 
and RASAL are activated by calcium influx, but differ in their response to calcium.  
CAPRI translocates from the cytosol to the plasma membrane when intracellular 
calcium levels rise (Lockyer et al., 2001; Walker et al., 2004) whereas RASAL 
cycles between the cytosol and the plasma membrane in response to the frequency 
of calcium oscillations (Liu et al., 2005; Walker et al., 2004). 
1.4.4 Other GAPs 
 SynGAP is a constitutively membrane associated RasGAP that is mainly 
present in the brain (Kim et al., 1998).  There is little information known about the 
regulation of this RasGAP; however, its activity is upregulated by serine 
phosphorylation by calmodulin-dependent protein kinase II (CaMKII) (Oh et al., 
2004).  Similarly, very little is known about the regulation of the activity of DAP2IP, 
an abundantly expressed RasGAP in mammalian cells (Wang et al., 2002). 
 
 
 
 
17 
 
1.5 Ras Effectors 
1.5.1 Raf  
The Raf kinase family was the first Ras effector identified and is the most 
thoroughly studied (Moelling et al., 1984; Rapp et al., 1983).  The mammalian 
genome contains 3 Raf genes that encode for three isoforms of Raf, C-Raf, A-Raf, 
and B-Raf, which are serine/threonine kinases.  Alternative spliced forms of A-Raf 
and B-Raf have also been identified.  Oncogenic B-RAF mutations have been 
identified in approximately 70% of human melanomas, making the involvement of B-
Raf in oncogenesis far greater than either C-Raf or A-Raf (Dhomen and Marais, 
2007).  
There are two regions of Raf proteins that associate with GTP-bound Ras:  
an N-terminal Ras binding domain (RBD) and an adjacent cysteine rich domain 
(CRD).  These motifs bind to specific domains of Ras.  The RBD interacts with the 
switch 1 region of Ras and the CRD binds to the switch II region.  In its inactive 
state, C-Raf is present in the cytoplasm bound to the scaffold protein 14-3-3.  The 
activation of C-Raf is highly complex and involves membrane recruitment, 
phosporlyation/dephosporylation events, and protein-protein interactions.  Binding 
of GTP-loaded Ras to Raf via the RBD and CRD results in the recruitment of Raf to 
the plasma membrane (Bondeva et al., 2002; Stokoe et al., 1994; Thorson et al., 
1998).  The recruitment event is necessary but not sufficient for Raf activation.  
Additionally, dephosphorylation of Ser43, Ser233, and Ser259 and phosphorylation 
of Ser621, Ser338, Tyr341, Thr491 and Ser494 are required.   Dephosphorylation of 
Ser43 removes the steric hindrance on the binding of the N-terminus of Raf to Ras.  
Dephosphorylation of Ser259 displaces 14-3-3 from this binding site, while 
phosphorylation of Ser621 allows 14-3-3 to bind to the C-terminus of Raf.  
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Phosphorylation of Ser338 and Tyr341 imparts a negative charge to the N-region of 
C-Raf.  The activation of A-Raf follows a similar pattern to that of C-Raf, while the 
activation of B-Raf is solely dependent upon Ras alone (Chong et al., 2001; 
Dhomen and Marais, 2007; Dumaz et al., 2002).  
Acitve Raf phosphorylates two downstream effectors, MEK1 and MEK2 on 
two serine residues in the activation segment.  Subsequently, MEK1 and MEK2 
activate ERK1 and ERK2 through phosphorylating threonine and tyrosine residues 
in their activation segments .  ERK phosphorylates a multitude of cytosolic and 
nuclear substrates, including transcription factors, cytoskeletal proteins, and kinases 
and phosphatases. This signaling cascade of Ras/Raf/MEK/ERK is known as the 
MAP kinase pathway.  This pathway leads to the regulation of cellular 
differentiation, proliferation, and survival and is commonly mutated in human 
cancers There are several scaffolding proteins that modulate the activation of the 
MEK-ERK cascade, including the Kinase suppressor of Ras-1 (KSR1), Connector 
enhancer of KSR (CNK), Paxillin and MEK partner-1 (MP1) (Kolch, 2005; Shaul and 
Seger, 2007; Yoon and Seger, 2006).   
Another interesting aspect of Raf signaling is the formation of C-Raf/B-Raf 
heterodimers.  This is dependent on GTP-Ras and 14-3-3.  These heterodimers 
have increased kinase activity compared to B-Raf and C-Raf 
monomers/homodimers due to dramatically elevated C-Raf kinase activity 
stimulated by B-Raf.  In contrast, C-Raf has no effect on B-Raf kinase activity 
(Garnett et al., 2005). 
1.5.2 Phosphatidylinositol 3-Kinase (PI-3K) 
 A second Ras effector essential for Ras transforming activity is PI3-K.  PI3-
kinases are heterodimers with a p85 regulatory subunit and a p110 catalytic 
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subunit.  The p85 subunit inhibits p110 catalytic activity of PI3-K.  The p110 subunit 
contains domains for membrane anchoring, interactions with p85 and Ras, and 
kinase activity.  PI3-kinases can be activated through two independent 
mechanisms:  binding of Ras-GTP to the p110 subunit or binding of p85 to 
phosphotyrosine residues on activated receptor tyrosine kinases, either directly or 
indirectly.  The p85-RTK interaction recruits the inactive p85-p110 complex to the 
plasma membrane and relieves the inhibitory effects of p85 on p110 (Krasilnikov, 
2000).  Activated p110 catalyses the phosphorylation of the 3’ hydroxyl group of 
phosphatidylinositol derivatives such as phosphatidylinositol-(4,5)-bisphosphate 
(PIP2) to generate phosphatidylinositol-(3,4,5)-triphosphate (PIP3).  PIP3 activates 
its main effector, AKT, and other downstream effector pathways.  PIP3 signaling is 
terminated by the action of phosphatases including PTEN, SHIP1, and SHIP2 
(Vivanco and Sawyers, 2002). 
The activation of AKT is dependent upon plasma membrane recruitment and 
phosphorylation at Thr308 and Ser473.  The membrane recruitment of AKT is 
mediated by the direct association of its N-terminal pleckstrin homology (PH) 
domain with the membrane-associated PIP3 (Rodriguez-Viciana et al., 1994).  
Phosphorylation of Thr308 is catalyzed by the PIP3-dependent protein kinase 
(PDK1), while Ser473 is phosphorylated by PDK2 (Alessi et al., 1997).   
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Figure 1.6.  Activation of Phosphatidylinositol 3-kinase (PI3-K) by Ras.   
Activation of the EGF receptor results in binding of the regulatory subunit of PI3-K, 
p85, to phosphorylated tyrosine residues of the receptor.  Consequently, the 
catalytic subunit of PI3-K, p110, is recruited to the plasma membrane.  PI3-K 
activity is enhanced further by the interaction between p110 and RasGTP.  
Phosphorylation of PIP2 by PI3-K produces PIP3 which recruits and activates 
PDK1.  PDK1 phosphorylates and activates protein kinase B (PKB) also known as 
Akt. 
 
AKT is a serine/threonine kinase which phosphorylates numerous substrates 
including BAD, mTOR, and MDM2 to mediate its effects in cell survival and 
proliferation.  PI3-kinases also signal through non-AKT pathways, including Cdc42 
and Rac1 which regulate cell motility, and SGK which regulates survival (Vivanco 
and Sawyers, 2002).   
1.6 Non-Redundant Functions of Ras Isoforms 
It is well established that Ras isoforms are highly homologous; however, 
several lines of evidence demonstrate that the functions of each Ras isoform are 
non-redundant.  Nonredundance was first suggested by analyses of the mutation 
rates of ras genes in cancers.  Ras mutations occur frequently in certain cancers, 
but the mutation rates of different isoforms vary significantly across different tumors.    
For example, mutations in the K-ras gene are associated with about 90% of 
pancreatic cancers, 50% of colorectal cancers, and 35% of non-small cell lung 
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cancers.  In contrast, H-ras mutations occur in 10% of transitional cell bladder 
cancers, while N-ras mutations occur in 30% of acute leukemia (Downward, 2003; 
Roberts and Der, 2007).  Interestingly, N-Ras mutations cause Noonan syndrome, a 
common autosomal dominant congenital disorder characterized as a type of 
dwarfism (Cirstea et al., 2010).  Among all ras mutations in cancers, K-ras accounts 
for more than 85%, 12% in N-ras, and 2% in H-ras (Lau and Haigis, 2009). 
Table 1.1 Frequency of Ras Mutations in Different Tumors 
Tumor Type Frequency (%) 
Pancreas 
Lung adenocarcinoma (non-small-cell) 
Colorectal 
Thyroid (Follicular) 
Thyroid (Undifferentiated papillary) 
Seminoma 
Melanoma 
Bladder 
Liver 
Kidney 
Myelodysplastic syndrome 
Acute myelogenous leukemia 
(Downward, 2003) 
90 (K) 
35 (K) 
45 (K) 
55 (H, K, N) 
60 (H, K, N) 
45 (K, N) 
15 (N) 
10 (H) 
30 (N) 
10 (H) 
40 (N, K) 
30 (N) 
 
 
Studies in knockout mice provide further evidence for functional divergence 
between Ras isoforms revealing that only the K-Ras 4B isoform is essential for 
mouse development. K-ras -/- mice die at two weeks of gestation with defects in 
myocardial and neural development (Johnson et al., 1997; Koera et al., 1997; 
Umanoff et al., 1995) while H-ras-/- and H-ras-/-/N-ras-/- mice display normal growth, 
fertility, and viability (Esteban et al., 2001; Ise et al., 2000).  Additionally, K-ras 4a-/- 
mice show normal growth and fertility with no abnormal histological pathology up to 
20-23 months of age (Plowman et al., 2006; Plowman et al., 2003). 
Moreover, all Ras isoforms share a common set of effectors, but engage 
them with different efficiencies.  In transformed fibroblasts, N-Ras binds C-Raf more 
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effectively than H-Ras.  The oncogenic properties of N-Ras are mediated by C-Raf 
in melanomas. Mutant K-Ras recruits and activates C-Raf with a higher efficiency 
and potency than N-Ras or H-Ras (Voice et al., 1999; Yan et al., 1998).  K-Ras also 
activates the Rac pathway more efficiently than H-Ras (Walsh and Bar-Sagi, 2001), 
while H-Ras is a more potent activator of PI3K than K-Ras (Voice et al., 1999; Yan 
et al., 1998). 
1.7 Compartmentalization of Ras Signaling 
1.7.1 Signaling on Plasma Membrane Nanodomains 
An intriguing area in Ras biology is compartmentalized signaling, In 
particular, at the plasma membrane.  Sophisticated high resolution imaging 
including electron microscopy (EM), fluorescence resonance energy transfer 
(FRET), and single particle trafficking (SPT) methods have led to a definitive picture 
of Ras organization on the plasma membrane (Plowman and Hancock, 2005).  The 
plasma membrane represents a complex mosaic of microdomains that results from 
the biophysical properties of the constituent lipids, cholesterol, and the actin 
cytoskeleton and the lateral assembly of sphingolipids and cholesterol into liquid 
ordered domains; therefore, imposing a non-random distribution on proteins across 
different nanoscale domains.  The plasma membrane is the major Ras signaling 
platform and is the site where Ras proteins function in distinct nanodomains called 
nanoclusters.  (Hancock, 2006; Kusumi et al., 2005b; Mayor and Rao, 2004).  
These nanoclusters are transient dynamic structures that are assembled by a 
complex interplay between components of Ras proteins and the plasma membrane.  
Vital components of the Ras protein include the farnesyl group and adjacent 
sequences of the hypervariable region.  Vital components of the plasma membrane 
include the actin cytoskeleton, scaffold proteins, and phospholipid/ cholesterol 
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composition (Harding and Hancock, 2008b).  Ras nanoclusters are comprised of 
~40% of Ras proteins that are arranged into clusters of 6-8 proteins on the plasma 
membrane.  The remaining Ras proteins are randomly arrayed as monomers on the 
plasma membrane (Hancock and Parton, 2005; Plowman et al., 2005; Prior et al., 
2003).  Ras nanoclusters have a radius of ~9nm and a lifetime of 0.1-0.4s (Hancock 
and Parton, 2005; Kusumi et al., 2005a; Kusumi et al., 2005b; Murakoshi et al., 
2004; Plowman et al., 2005).  The function of Ras nanoclusters in Ras signal 
transduction is to recruit Ras effectors such as Raf, MEK, and ERK.  Inhibition of 
Ras nanocluster assembly abrogates Ras signal output even if Ras is active and 
localized to the plasma membrane (Plowman et al., 2008; Plowman et al., 2005; 
Tian et al., 2007).  Additionally, in MAPK signaling, Ras nanoclusters function as a 
digital switch converting graded ligand inputs into fixed outputs of ERK.  The 
generation of Ras nanoclusters that are in direct proportion to ligand input allows 
cells to build an analogue-digital-analogue circuit relay.  This signal is transmitted in 
high fidelity across the plasma membrane (Harding et al., 2005; Inder and Hancock, 
2008; Inder et al., 2008). 
Ras isoforms are localized to spatially distinct, non-overlapping nanoclusters 
on the plasma membrane.  GTP-bound H-Ras is mainly localized to cholesterol 
independent nanoclusters that are stabilized by galectin-1, a cytosolic scaffold 
protein.  In its inactive, GDP- bound conformation, H-Ras is present in cholesterol 
dependent nanoclusters that require an intact actin cytoskeleton (Belanis et al., 
2008; Plowman et al., 2005; Prior et al., 2001; Prior et al., 2003).  The GTP-
dependent lateral segregation of N-Ras is opposite to that of H-Ras.  When GTP-
loaded, N-Ras is present in cholesterol dependent domains, but shifts to cholesterol 
independent domains when GDP-loaded (Roy et al., 2005).  On the contrary, GDP- 
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and GTP-bound K-Ras is localized to cholesterol-independent nanoclusters that are 
partially dependent upon the actin cytoskeleton.  GTP-loaded K-Ras requires the 
galectin-3 scaffold and GDP-loaded K-Ras does not (Elad-Sfadia et al., 2004; 
Plowman et al., 2005; Prior et al., 2003). 
1.7.2 Signaling on Endosomes 
 Endosomes were the first intracellular compartment implicated in Ras 
signaling.  Subcellular fractionation studies provided initial insights into endosomal 
Ras signaling with evidence of Shc, Grb2, Sos, and C-Raf localization to 
endosomes following EGF stimulation (Di Guglielmo et al., 1994; Pol et al., 1998).  
Additionally, protein tyrosine kinase receptors (PTKRs), such as the EGF receptor 
(EGFR), were demonstrated to remain active upon internalization on endosomes 
(Burke et al., 2001).  Moreover, Ras isoforms are localized to endosomes in 
response to growth factor stimulation or ubiquitination (Jura et al., 2006; Pol et al., 
1998).  H-Ras and N-Ras signaling require endocytosis, while K-Ras signaling does 
not (Omerovic et al., 2007; Roy et al., 2002).  Recent work revealed that 
palmitoylated Ras proteins (H-Ras and N-Ras) are directed to recycling endosomes 
(REs).  The current belief is that REs also serve as a way-station for Ras proteins 
as they traffic to the plasma membrane (Misaki et al., 2010). 
1.7.3 Signaling on the Golgi 
 Live cell imaging using GFP-RBD, a probe that selectively binds Ras-GTP, 
showed that the Golgi apparatus and plasma membrane are both sites for Ras 
activation.  Activation of Ras on the plasma membrane occurs rapidly and 
transiently (onset within 1 minute, 10 minute duration) after stimulation with the 
epidermal growth factor (EGF), whereas activation of Ras on the Golgi is sustained 
and delayed (onset within 10 minutes, 60 minute duration).  The Ras isoforms 
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involved are believed to be H-Ras and N-Ras, since these isoforms shuttle between 
the plasma membrane and the Golgi. K-Ras 4B is not present on the Golgi and is 
not thought to engage in this process. Interestingly, activation of the Golgi pool of 
Ras was found to occur independently of the endocytic pathway when it was 
unaffected by dominant negative epsin or a temperature block, factors that block 
endocytosis and vesicular transport respectively (Bivona and Philips, 2003; Chen et 
al., 1998; Chiu et al., 2002).   
Drawbacks of GFP-RBD include its inability to detect endogenous activated 
Ras unless a GEF is overexpressed and its dependence on the overexpression of 
wild-type Ras isoforms (Quatela and Philips, 2006).  A similar probe was later 
created which involved the use of C-terminally tagged RBD constructs with GFP 
(Walker and Lockyer, 2004) and the use of both the RBD and CRD domains of C-
Raf tagged with GFP.  Expression of the latter (RBD-CRD) generates a stronger 
interaction with Ras on the membrane than RBD alone.  In striking contrast, active 
Ras was only observed on the plasma membrane (Bondeva et al., 2002). 
Other methods for investigating Ras signaling on the Golgi apparatus have 
involved the use of Flourescence Resonance Energy Transfer (FRET)-based Ras 
activity probes. The first attempt was use of the novel Raichu-Ras FRET probe that 
assayed active Ras by reporting the sum of GEF and GAP activities.  The probe 
localized exclusively to the plasma membrane.  An explanation for this is that the 
Raichu-Ras probe included the HVR of K-Ras for membrane attachment (Mochizuki 
et al., 2001; Walker and Lockyer, 2004).  Subsequent studies to detect FRET 
between YFP-RBD and active CFP-Ras also failed to report active Ras on the Golgi 
(Jiang and Sorkin, 2002; Ohba et al., 2003).  Additionally, the use of full-length C-
Raf as a FRET reporter for active Ras has given mixed success to demonstrate the 
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Golgi as a site for Ras signaling.  This may be due to the complex regulation of its 
membrane recruitment (Bondeva et al., 2002; Hibino et al., 2003; Jiang and Sorkin, 
2002).   
Despite the inconsistency in Golgi studies, there are several lines of 
evidence that demonstrate Golgi signaling from Ras is important.  Research in T 
cells show that low-grade stimulation of the T cell receptor is specific to N-Ras and 
only occurs on the Golgi (Perez de Castro et al., 2004).  Additionally, in thymic 
selection, negative selection is related to ERK dynamics on the plasma membrane, 
while positive selection correlates with Golgi-mediated ERK activation (Daniels et 
al., 2006).  Furthermore, activation of ERK on the Golgi generates a graded 
response, and plasma membrane-mediated ERK activation produces a digital or 
switch-like response (Inder and Hancock, 2008). 
The mechanism behind Golgi-associated activated Ras was revealed in 
Jurkat T cells stimulated by the activation of the T-cell receptor.  Phospholipase Cγ 
(PLCγ) is responsible for activating Ras on the Golgi.  PLCγ is an enzyme that 
produces diacylglycerol (DAG) and inositol triphosphate (IP3). IP3 releases calcium 
into the cytosol which leads to the accumulation and recruitment of the Ras GEF, 
RasGRP1, on the Golgi.  RasGRP1 is controlled by both DAG and calcium and has 
affinity for the Golgi membrane. The requirement of RasGRP1 was revealed when a 
dominant interfering mutant of this GEF inhibited Ras activation of the Golgi and 
silencing of RasGRP1 with short interfering RNA abrogated the activation of Ras on 
this compartment.  Furthermore, calcium promoted inactivator (CAPRI), a negative 
regulator of R\as, was shown to inhibit Ras activation at the plasma membrane in 
Jurkat T cells (Bivona et al., 2003).  
 
27 
 
1.7.4 Signaling on the Endoplasmic Reticulum (ER) 
Whether or not Ras can signal from the ER remains controversial.  The 
strongest evidence of signaling on the ER comes from studies in yeast.  In 
Saccharomyces cerevisiae, an ER-restricted Ras effector was discovered known as 
ER-associated Ras inhibitor (ERi1).  The function of this protein is to preferentially 
bind to the effector loop of GTP-loaded Ras to inhibit Ras localized to the ER 
(Sobering et al., 2003).  Eri1 is a component of GPI-GlcNAc transferase, an enzyme 
involved in the rate-limiting step in the biosynthesis of GPI-anchors.  Interestingly, 
GTP-bound Ras2 binds to and inhibits the activity of this enzyme in the absence of 
Eri1 (Sobering et al., 2004).  Further evidence for ER signaling comes from studies 
in the fission yeast, Schizosaccharomyces pombe (S. pombe).  Since S. pombe has 
only one Ras protein, Ras1, that regulates two different pathways, it provides a 
simple system that can be used to study compartmentalized Ras signaling.   Ras1 
controls mating through a Byr2-mitogen-activated protein pathway while maintaining 
elongated cell morphology through the Scd1-Cdc42 pathway.  In these studies, 
Ras1 mutants were constitutively targeted to the ER/Golgi or the plasma 
membrane.  In ras1 null cells, the ER/Golgi restricted Ras1 mutant supported 
morphology, but not mating.  On the contrary, the plasma membrane restricted 
Ras1 mutant supported mating, but not morphology.   These observations support 
the idea that Ras may signal from the ER (Chang and Philips, 2006).   
In mammalian cells, the expression of palmitoylated deficient N-Ras or H-
Ras results in cytosolic and endoplasmic reticulum (ER) localized Ras (Choy et al., 
1999). Coexpression of the Ras-GTP fluorescent reporter, GFP-RBD, with 
unpalmitoylated H-Ras confirmed that Ras is activated on the ER in response to 
epidermal growth factor stimulation.  Furthermore, restricting constitutively active H-
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Ras to the ER with the transmembrane motif of the avian bronchitis virus M1 protein 
to measure signal output reveals poor activation of Erk and Akt pathways (Chiu et 
al., 2002).  The Ras GEF, RasGRF, is responsible for activation of H-Ras on the 
endoplasmic reticulum (Arozarena et al., 2004). 
1.7.5 Signaling on the Mitochondria and Nucleus 
Another potential signaling platform for Ras is on the mitochondria.  The 
three main Ras isoforms are present in mitochondrial fractions of an IL-2-dependent 
murine T cell line.  Further analysis revealed that Bcl-2 targets K-Ras to the 
mitochondria in an IL-2 dependent manner, while mitochondrial Ras does not 
require IL-2 (Wang et al., 1996).  A recent study has reported that the association of 
K-Ras with Bcl-2 is regulated by protein kinase C in Jurkat T cells contributing to 
apoptosis (Bivona et al., 2006).  The postulation that Ras may signal from the 
mitochondria is intriguing; however, the extensive literature on Ras localization by 
microscopy does not report localization on the mitochondria.  Moreover, a novel 
splice variant of H-Ras, p19, was characterized and is present in the nucleus and 
the cytoplasm.  Another study revealed that nuclear p19 activates p73 with help 
from the MDM2 protein (Mor and Philips, 2006). 
1.8 Perspective  
In this study, we will investigate the role of single, endogenous Ras isoforms 
(H-Ras and K-Ras) on plasma membrane nanodomains and the Golgi.  To 
accomplish our aim, we sought to develop tools whereby the signaling of individual 
endogenous Ras isoforms can be abolished.  The bulk of the aforementioned 
studies have relied on the overexpression of Ras to comprehend Ras function on 
the plasma membrane and the Golgi and no isoform-specific anti-Ras tools have 
been successfully developed; thus the significance of Ras isoforms on these 
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compartments remains unresolved.  The establishment of such tools will potentially 
increase the understanding of Ras biology. 
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Chapter 2. Materials and Methods 
 
 
 
 
 
 
 
 
 
 
 
31 
 
2.1 Chemicals  
 All chemicals were purchased from Sigma Aldrich unless otherwise stated. 
2.2 DNA Constructs 
 All GFP-GAP-Ras constructs (GFP-GAP, GFP-GAP-CTH, GFP-GAP-CTK, 
and GFP-GAP-CTH 181S) were cloned as follows.  For GFP-GAP subcloning, 
pEXVkidGAP (Huang et al., 1993) was digested using Sac1 and EcoR1 restriction 
enzymes (New England Biolabs).  The 1000bp kidGAP fragment was inserted into 
Sac1/EcoR1 digested pEGFP-C1.  The Sac1 site was removed by T4 DNA 
polymerase (New England Biolabs).  For GFP-GAP-CTH, GFP-GAP-CTK, and 
GFP-GAP-CTH 181S cloning, the HVRs of H- and K-Ras were cloned onto the C-
terminus of pEGFP-C1-GAP by PCR amplification.  This was performed through the 
PCR amplification of the CTH, CTK, and CTH 181S sequences from pEGFP-C1-
CTH, pEGFP-C1-CTK, and pEGFP-C1-CTH 181S with a reverse GFP sequencing 
primer (5’CTACAATGGGTATGGC 3’) and the following forward primers: 5’ 
CCGAATTCAGCACAAGCTGCGGAAGCTGAACC 3’ for pEGFP-C1-GAP-CTH and 
pEGFP-C1-GAP-CTH 181S and 5’ GGGAATTCAGCATAAAGAA 
AAGATGAGCAAAGATGG 3’ for pEGFP-C1-GAP-CTK.  Furthermore, the PCR 
products were digested with EcoR1/BamH1 and were inserted into EcoR1/BamH1 
digested pEGFP-C1-GAP. 
2.3 Cell Growth and Maintenance  
 The following cells were used:  BHK, Cos-1, and PC12.  All cells were grown 
and maintained in 37°C with 5% CO2 injection using Dulbecco’s Modified Eagle 
Medium (DMEM) (Hyclone) with additives including 1% sodium pyruvate and 
glutamax (Gibco).  For PC12 cells, the medium was also supplemented with 10% 
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horse serum and 5% fetal bovine serum (FBS).  BHK and Cos-1 cells were cultured 
in medium containing 10% bovine calf serum (BCSS) and 10% FBS, respectively. 
2.4 Cell Transfection and Stimulation 
 For Ras-GTP pulldown assays, BHK cells were transiently transfected by the 
lipofection method with pEGFP, GFP-GAP, GFP-GAP-CTH, GFP-GAP-CTK, or 
GFP-GAP-CTH181S using Lipofectamine 2000 reagent (Invitrogen) in 15 cm 
dishes.  For GFP, GFP-GAP, GFP-GAP-CTH, and GFP-GAP-CTK transfections, 
36µg DNA and 40µL Lipofectamine 2000 reagent was used.  To achieve optimal 
transfection efficiency all dishes were gently shaken for at least 10 times.  Cells 
were returned to growth medium 3hrs after lipofection.  For GFP-GAP-CTK 
transfections, twice as much DNA (72µg) was used and cells were incubated in 
transfection mixture for at least 8hrs prior to returning to growth medium.  
Approximately 16hrs after transfection, cells were washed twice with Phosphate 
Buffered Serum (PBS) (Hyclone) and cells were incubated in serum free medium 
(DMEM) for 1hr.  Subsequently, the serum-free medium containing 50 ng/ml EGF 
was added to cells for the following time points: 2, 5, 10, 20, 40, and 60min.  
Immediatley following EGF stimulation for each time period, EGF medium was 
removed and cells were washed twice with ice cold PBS.  PBS was then replaced 
by 1mL Lysis Buffer B (50mM Tris pH 7.5, 75mM NaCl, 25mM NaF, 5mM MgCl2, 
5mM EGTA, 0.33 µg/mL aprotinin, 100µM Na3VO4, 3.33 µg/mL leupeptin, 1mM 
DTT, and 1% NP40). Cells were incubated in Lysis Buffer B for at least 10min 
before removal from dishes using a cell scraper.  Cell lysates were transferred into 
1.5 mL eppendorf tubes and vortexed.  The insoluble material was removed by 
centrifugation at 13,000 rpm for 5min and the remaining supernatant stored on ice 
for further analysis.  
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For Ras signaling experiments, BHK cells were transiently transfected with 
Lipofectamine 2000 reagent in 6 cm dishes.  For GFP, GFP-GAP-CTH, and GFP-
GAP-CTH181S transfections, 8µg DNA and 20µL Lipofectamine 2000 reagent was 
used.  Cells were returned to growth medium 4hrs after lipofection.  For GFP-GAP –
CTK transfections, 16µg DNA was used and cells were incubated in transfection 
mixture for at least 8hrs prior to returning to growth medium.  Approximately 16hrs 
after transfection, cells were washed twice with Phosphate Buffered Serum (PBS) 
(Hyclone), and cells were incubated in serum free medium (DMEM) for 1hr.  
Subsequently, the serum-free medium containing 50 ng/ml EGF was added to cells 
for the following time points: 5, 10, 20, 40, and 60min.  Immediately following EGF 
stimulation for each time period, EGF medium was removed and cells were washed 
twice with ice cold PBS.  PBS was then replaced by 150µL Lysis Buffer B.  Cells 
were incubated in Lysis Buffer B for at least 10min before removal from dishes 
using a cell scraper and cell lysates were prepared as described above.  
 For confocal microscopy studies, BHK cells were treated the same as Ras 
signaling experiments; however cells were transfected on coverslips in 6 well plates 
and fixed instead of harvested.  See Confocal Microscopy for fixation conditions.   
PC12 cells were transiently transfected on coverslips by the lipofection method with 
pEGFP, GFP-GAP-CTH, GFP-GAP-CTK, or GFP-GAP-CTH181S GFP using 
Lipofectamine 2000 (Invitrogen) in 6 well plates.  PC12 cells were transfected using 
the same conditions as the Ras signaling experiments.  Three hours after 
lipofection, the cells were returned to growth medium.  Approximately 24hrs after 
transfection, cells were washed twice with PBS and fresh growth medium containing 
100 ng/ml NGF was added.  Cells were placed in a CO2 incubator at 37°C for an 
additional 72hrs to assess neurite outgrowth under a confocal microscope.   
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2.5 Bradford Assay 
 Following cell harvesting with Lysis Buffer B, the protein concentration for 
each sample was determined.  Samples were centrifuged at 13,000 rpm for 5 min.  
The pellet was discarded and the supernatant was sonicated for homogenization.  
BSA protein standards ranging from 200-1000 ng/µL were used. Samples were 
diluted as needed and were analyzed in triplicates by pipetting 5µL of sample into a 
96 well plate. The absorbance was measured at 595 nm using a 
spectrophotometer.  The protein concentration of the unknown sample was 
determined from a graph of the standard curve of ng of BSA verses the absorbance.   
2.6 Western Blot Analysis 
 Proteins were separated on 12% SDS-PAGE. Electrophoretic transfer onto 
polyvinlyidene fluoride (PVDF) membrane was performed at 25 volts for 30min. 
using a semidry transfer apparatus (Model: Trans-Blot SD Cell, Bio-Ras).  After the 
transfer, blots were stained with Commassie Blue to evaluate transfer efficiency.  
Membranes were incubated for 1hr at room temperature in blocking buffer (5% dry 
non-fat milk in 1X TBS (20mM Tris, 137mM NaCl, pH 7.6 with HCL) and 0.1% 
Tween-20 for non-phospho-blots; 3% BSA in 1X TBS and 0.1% Tween-20 for 
phosphor-blots.  Membranes were subsequently probed with primary antibodies 
diluted in the appropriate blocking buffer for 2hrs at room temperature.  The 
membranes were washed 3 times for 5min with a washing buffer (1X TBS, 0.1% 
Tween-20), and then incubated in the appropriate secondary antibody for 1hr at 
room temperature.  All antibody incubations were performed on a shaker.  Following 
antibody incubations, the membranes were treated with chemiluminescence 
detection reagents (SuperSignal West Dura Stable Peroxide/ Luminal-Enhancer 
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Solutions or SuperSignal West Stable Peroxide/Luminal-Enhancer Solutions, 
Thermo Scientific and analyzed by quantifying each lane using the FluorChem Q.  
2.7 Antibodies used for Western Blotting 
 The following antibodies were from Cell Signaling:  phosphor-Akt (Ser473), 
rabbit monoclonal antibody; Akt (pan), mouse monoclonal antibody; p44/42 MAPK 
(ERK ½), rabbit monoclonal antibody; HA-tag, and mouse monoclonal antibody.  
ERK2 and H-Ras rabbit polyclonal antibodies were from Santa Cruz Biotechnology.  
Anti-GFP and Anti-K-Ras mouse monoclonal antibodies were form Sigma.  Anti-Ras 
(mouse monoclonal antibody) was from BD Transduction Laboratories.  Goat anti-
mouse and anti-rabbit antibodies were from Invitrogen. 
2.8 Confocal Microscopy 
 BHK and Cos-1 cells were transfected on coverslips.  PC12 cells were 
transfected on coverslips that were previously coated with poly-L-lysine.  Cells were 
washed 3 times with PBS and fixed with 4% paraformaldehyde/PBS solution for 30 
min at room temperature followed by washing steps with PBS and water.  
Coverslips were mounted on slides in Mowiol  for confocal microscopy.  Slides were 
allowed to dry for at least 1hr at 37°C prior to use of the A1 Nikon Confocal 
Microscope.   
2.9 Golgi Staining 
 BHK cells were transfected on coverslips as previously described.  The day 
after transfection, cells were exposed to the components of the Organelle LightsTM 
Intracellular Targeted Green Fluorescent Proteins kit (Contents: Organelle Lights 
reagent, BacMam enhancer, Dimethylsulfoxide (DMSO), Invitrogen)  The Organelle 
Lights reagent consists of a baculovirus which is responsible for directing the 
expression of autofluorescent proteins (in this case the Golgi resident enzyme, N-
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acetylgalactosominyltransferase 2) to a specific subcellular location.  The growth 
medium was replaced with diluted Organelle Lights reagent (Component A) as 
explained in the manufacturer’s instructions.  Cells were allowed to incubate for 
2hrs with gentle rotation at room temperature.  Following incubation, the reagent 
was replaced with growth medium containing diluted enhancer (Component B and 
C) and cells were placed in the incubator for 2hrs.  Finally, cells were fixed as stated 
before in preparation for observation of Golgi staining by confocal microscopy. 
2.10 GST-RBD (Ras Binding Domain of Raf-1) Pull-down Assay 
 
2.10.1 Expression of GST-RBD in bacteria 
 For GST-RBD expression, 50 ml of Luria broth (L-broth) supplemented with 
100 ug/ml of ampicillin was inoculated with plasmid name here GST-RBD K85A 
glycerol stock and incubated overnight at 37°C with constant agitation.  The 50ml 
culture was then added to 2L of L-broth containing 100 µg/ml ampicilin and 
incubated at 37°C with agitation for approximately 4hrs or until the culture reached 
an OD600 value of 0.6.  After incubation, 0.2 mM IPTG was added to the culture with 
subsequent incubation for another 4hrs under the same conditions.  The bacterial 
cells were pelleted by centrifugation at 6000 rpm for 15min at 4°C. 
2.10.2 Purification and Storage of GST-RBD 
For purification of GST-RBD, the bacterial cells above were resuspended in 
30ml STE buffer (10 mM Tris (pH 8.0 with HCl), 150 mM NaCl, 1 mM EDTA, 
100µg/ml lysozyme, and 1 mM PMSF).  The suspension was incubated at 4°C on a 
rotator.  Following incubation, 5 mM DTT and 1.5% N-Laurylsarcosine sodium salt 
(prepared in STE buffer) was added to the suspension.  The cells were shaken 
vigorously and sonicated on ice for 1min at the maximal power level using the name 
here.  The cells were thoroughly mixed with 3% Triton X-100 (prepared in STE 
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buffer) and incubated on ice for 30min.  After incubation, cells were sonicated as 
previously described.  Insoluble material was pelleted by centrifugation at 13,000 
rpm for 20min at 4°C.  The supernatant was mixed with 4ml of a 50% suspension of 
glutathione agarose beads (Sigma Aldrich) overnight on a rotator at 4°C.  Following 
overnight incubation, the beads were washed 6 times for 10min in a mixture of PBS 
and 0.1% Triton X-100.  The beads were resuspended in 4ml of storage buffer (50 
mM Hepes (pH 7.4 with HCl), 150 mM NaCl, 5 mM DTT and 10% sterile glycerol) 
as a 50% suspension.  The beads were checked for the bound fusion protein, GST-
RBD, by SDS-PAGE gel. Aproximately 20µl of GST-RBD beads (50% suspension) 
and 5µl of 5X sample buffer were loaded onto a 12% gel after being boiled at 95°C 
for 5min.  The gel was stained with Coomassie Blue for approximately 5min and 
washed 3 times for 3min with destaining solution (10% acetic acid, 50% methanol) 
to view the GST-RBD fusion protein band.  Finally, the beads were stored for future 
use as aliquots that were snap frozen on dry ice and stored at -80°C. 
2.10.3 Ras GTP Pull-down Assay 
 After each time point of EGF addition, cells were immediatedly placed on ice 
followed by 2 washes with ice-cold PBS.  The PBS was removed and cells were 
harvested in 1ml of ice-cold lysis buffer with a cell scraper.  Insoluble material was 
pelleted by centrifugation at 13,000 rpm for 5min.  The pelleted material was 
discarded, and the protein concentration of the supernatant was determined by the 
Bradford Assay.  A total of 1mg of protein was used for the pulldown assay and 
20µg of protein was set aside for immunoblotting to determine protein input.  For the 
pulldown assay, the protein was combined with 1ml of binding buffer (50 mM Tris 
pH 7.5, 10 mM MgCl2, 0.5 mg/ml BSA, 0.5 mM DTT, 100mM NaCl) and 20µl of 
GST-RBD beads described previously.  The new protein mixture was allowed to 
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incubate on a rotator overnight at 4°C.  The following day, the mixture was spun 
down at 13000 rpm for 1min to separate the beads from the buffer.  The 
supernatant was removed and replaced with 1ml of binding buffer and placed on the 
rotator for 5 minutes.  This washing procedure was repeated for 2 more times with 
the final step of separating the beads from the buffer by centrifugation as described 
previously.  The supernatant was removed and discarded.  The beads were mixed 
with 5µl of 5x sample buffer and were boiled at 95°C for 5min in preparation for 
immunoblotting against Ras proteins. 
2.12 Proliferation Assay 
 BHK cells transiently transfected with GFP-tH or GFP-GAP-Ras constructs 
were analyzed by FACS (BDFortessa).  Prior to FACS analysis, BHK cells were 
transiently transfected using the same conditions as Ras signaling experiments.  
Cells were plated in 24 well plates in triplicates.  Each day cells were harvested 
using trypsin/EDTA solution.  The number of GFP expressing cells was quantified 
and recorded for each day. 
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Chapter 3.  Results 
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3.1 Introduction 
 It is unclear how individual endogenous Ras isoforms function on plasma 
membrane nanodomains and the Golgi in cells.  Multiple strategies have been 
utilized in an attempt to reveal the functions of each Ras isoform.  K-Ras null cells 
were used to determine the role of K-Ras.  However, these cells do not express 
both K-Ras4B and K-Ras4A, making the effects of K-Ras4B difficult to isolate.  RNA 
interference had also been used but failed to equally down-regulate all Ras isoforms 
(Khanzada et al., 2006).  Dominant negative mutants of Ras isoforms are also 
inadequate as they fail to act specifically on one endogenous Ras isoform 
(Matallanas et al., 2003).  Moreover, all the above studies do not acknowledge the 
localization of Ras proteins to the Golgi making it difficult to differentiate between 
Ras isoform-specific signaling from the plasma membrane and the Golgi.  Tools that 
will allow us to specifically target endogenous Ras proteins on these compartments 
are needed to effectively determine the role of endogenous Ras isoform-specific 
signaling.  
 Ras signaling from the Golgi is a controversial topic as not all investigations 
have been able to demonstrate Golgi-localized Ras activity.  Nevertheless, at 
steady state, palmitoylated Ras isoforms such as H-Ras are present on the plasma 
membrane as well as the Golgi, and furthermore, 2 models for Ras activation on the 
Golgi have been previously described.  In the first model, described in T cells, Ras 
activation occurs directly on the Golgi where Ras is activated by Src-dependent 
activation of phospholipase C-γ1 (PLC-γ1) resulting in an increase in diacylglycerol 
(DAG) and the subsequent translocation of the RasGEF RasGRP1 from the cytosol 
to the Golgi.  RasGRP1 can also activate Ras on the plasma membrane in 
response to co-stimulation by the T cell receptor and the integrin LFA-1.  Another 
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model suggests active Ras-GTP on the Golgi is derived from the plasma membrane 
due to a rapid and continuous depalmitoylation/re-palmitoylation cycle that occurs 
after posttranslational modifications of the Ras C-terminus.  Either way, recent 
reports indicate that Ras signaling from the Golgi is important.  Studies in yeast 
reveal that Ras signaling from the endomembrane controls morphology, while Ras 
signaling from the plasma membrane regulates mating.  In mammalian cells, the 
kinetics of Ras activation on the Golgi are different from the plasma membrane as 
well as the kinetics of ERK output.  In thymocyte selection, endogenous Ras 
signaling from the Golgi is essential for positive selection, whereas Ras signaling 
from the plasma membrane is required for negative selection.  However, whether or 
not Golgi activation of endogenous Ras has physiological relevance is still largely 
unknown. 
 Here, we design novel tools to target endogenous H-Ras or K-Ras isoforms 
and abrogate Ras signaling on the compartments mentioned above.  A critical 
component for the localization of Ras to various compartments in the cell is the 
hypervariable region (HVR) which encodes the membrane anchors and the 
adjacent sequences required for membrane targeting (Hancock, 2003).  Predicated 
on this vital role of the HVR, we hypothesize that, when fused to GAP, the HVR of 
Ras isoforms will target GAP to Ras nanoclusters on the plasma membrane and to 
the Golgi and selectively inhibit endogenous Ras activity.  Specifically, we aim to 
demonstrate that each targeted GAP construct will correctly confine to areas where 
the cognate Ras isoform is present.  This is important, because it alludes to their 
ability to abrogate specific Ras isoform activation on the plasma membrane and the 
Golgi.  Next, we will investigate the ability of each targeted GAP construct to 
abrogate the activation of endogenous Ras isoforms and the specificity of these 
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GAP constructs on the corresponding Ras isoform.  The inhibition of endogenous 
Ras isoforms will allow us to investigate the function of Ras isoform-specific 
signaling on two separate compartments of the cell, an approach which has never 
been done.  This will include an investigation of the ability of Ras isoform-specific 
inhibitors to abrogate Ras signal transduction.  We are particularly interested in two 
Ras dependent signaling pathways, Raf/MEK/ERK and PI3-K/Akt, because these 
pathways are the only Ras effector pathways that are also commonly mutated in 
human cancer (De Luca et al., 2012).  Finally, we will examine the physiological 
relevance of Ras signaling from the plasma membrane and the Golgi.  Our findings 
may provide new insights into Ras function. 
3.2 Results 
3.2.1 The HVR Targets GFP-RasGAP to the Plasma Membrane and Golgi 
 In an effort to create proteins that specifically inhibit GTP-loaded H-Ras and 
K-Ras on plasma membrane nanodomains and on the Golgi, we constructed GAP 
molecules that are targeted to specific sub-cellular compartments.  First, we sub-
cloned the catalytic GAP domain (amino acids 701-1044) of p120RasGAP (Huang 
et al., 1993) onto the C-terminus of GFP in the enhanced green fluorescent protein 
plasmid, pEGFP.  As depicted in Figure 3.1, full-length p120RasGAP has only one 
region, the catalytic GAP domain, which interacts with GTP-bound Ras and thus is 
responsible for hydrolyzing GTP to GDP, converting active Ras to inactive Ras 
(Mitin et al., 2005). 
 Secondly, we cloned the complete carboxyl HVRs of H-Ras (amino acids  
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Figure 3.1 Full-length p120RasGAP.  Schematic illustrating the domains of 
p120RasGAP and their known functions. 
 
166-189) or K-Ras (amino acids 166-188) by PCR amplification onto the C-terminus 
of pEGFP-GAP.  The HVR or the C-terminus of H-Ras or K-Ras (CTH or CTK) is 
necessary and sufficient for its membrane targeting.  Previous work has shown that 
GFP-CTH and GFP-CTK undergo the same trafficking pathway as full length H-Ras 
and K-Ras, respectively (Apolloni et al., 2000). 
 
Figure 3.2. Schematic representation of Ras and nomenclature of regions.  
Illustration of full-length Ras isoforms and the extreme C-terminal domain called the 
hypervariable region (HVR).  The HVR is divided into two parts:  the linker and 
membrane anchor domains.  The C-terminal HVR of H-Ras (residues 166-189) is 
denoted by CTH or CTH181S and the HVR of K-Ras (residues 166-188) is denoted 
by CTK. 
Additionally, these HVRs target exogenous proteins to specific plasma membrane 
nanodomains that co-localize with the corresponding GTP-loaded Ras isoform 
(Inder et al., 2008).  Finally, we created a third construct by introducing a point 
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mutation in the HVR of H-Ras at position C181, changing the cysteine to serine as 
previously described (Inder et al., 2008).  The 181S mutation disables forward 
trafficking to the plasma membrane causing the protein to remain in the Golgi (Roy 
et al., 2005).  Illustrated in Figure 3.2 are the C-terminal HVRs of H-Ras or K-Ras 
mentioned above. The organization of these GFP-RasGAP proteins is displayed in 
Figure 3.3.  We predict that GFP-GAP-CTK will localize exclusively to the plasma 
membrane, while GFP-GAP-CTH will localize predominantly to the plasma 
membrane and partially to the Golgi.  GFP-GAP- CTH181S will localize almost 
exclusively to the Golgi. 
 
 
Figure 3.3. GFP-RasGAP proteins.  Schematic demonstrating the organization of 
GFP-RasGAP proteins. 
 
 
To validate the localization of RasGAP proteins, each protein was transiently 
expressed into Baby Hamster Kidney (BHK) cells and the localization visualized in 
fixed cells by fluorescence microscopy. Figure 3.4 shows that the controls, GFP  
and GFP-GAP, did not localize to any membrane, but instead decorated the cytosol 
and nucleoplasm.  For detection of the Golgi, cells expressing GFP-GAP-CTH and 
GFP-GAP-CTH181S were stained with a RFP-Golgi marker (N-
acetylgalactosaminyltransferase-2) prior to fixation and imaging.  As expected, 
GFP-GAP-CTK exclusively localized to the plasma membrane like K-Ras. GFP-
GAP-CTH predominantly localized to the plasma membrane, but with some degree 
of intracellular staining.  GFP-GAP-CTH181S co-localized with the RFP-Golgi 
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Figure 3.4. The HVR targets GFP-RasGAP to the Plasma Membrane and Golgi. 
BHK cells transiently expressing GFP-RasGAP proteins were stained with a RFP-
Golgi marker followed by fixation on coverslips.  The sub-cellular localization of 
each GFP-RasGAP protein was visualized by fluorescence microscopy. 
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marker, indicating the presence of a Golgi pool, although a very small amount of the 
GFP-RasGAP protein was also present on the plasma membrane.  Taken together, 
these observations revealed that the membrane distributions of GFP-RasGAP 
proteins were directed by the HVR of H-Ras or K-Ras and may co-localize with full-
length Ras proteins.  Therefore, the cellular localization of each GFP-RasGAP 
protein was as predicted, demonstrating their potential to specifically abrogate 
individual endogenous GTP-loaded Ras isoforms.  
 
 
 
Figure 3.5. Equivalent Expression of GFP-RasGAP Proteins.  Wild-type BHK 
cells and BHK cells transiently expressing GFP-RasGAP proteins were analyzed by 
immunoblot using anti-GFP antibody for equivalent expression.  This blot serves as 
a representative blot for all GFP-RasGAP transfections. 
 
3.2.2 GFP-RasGAP Proteins Specifically Inhibit Endogenous Ras Isoforms 
 We next examined the ability of GFP-RasGAP proteins to specifically 
abrogate activation of individual endogenous Ras isoforms.  Therefore, we prepared 
whole cell lysates (WCLs) from BHK cells and BHK cells transiently expressing 
GFP-RasGAP proteins.  These were then immunoblotted with anti-GFP (Figure 3.5) 
to confirm equivalent expression of GFP-RasGAP proteins.  To observe Ras 
activation in response to a specific growth factor, quiescent BHK cells transfected 
with GFP-RasGAP constructs were stimulated with a saturating dose of EGF (50 
ng/mL) at various times ranging from 2 to 60min.  Following stimulation, 
endogenous GTP-bound Ras proteins were isolated by GST-RBD pull-down and 
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the levels of GTP-bound Ras were detected by immunoblotting with a pan-Ras, H-
Ras, or K-Ras antibody.  As demonstrated in Figure 3.6, the kinetics of Ras 
activation in control cells (Empty Vector) show maximal levels of GTP-loaded Ras 
proteins (H-Ras, K-Ras, and N-Ras) occurring rapidly at 2 min. followed by a return 
to basal levels around 60min.  Cytosolic GAP or GFP-GAP did not have any effect 
on total GTP-loaded Ras levels.  This was expected since GFP-GAP did not occupy 
any membrane structure in BHK cells as visualized by fluorescence microscopy; 
thus, displaying the importance of the HVR for targeting exogenous proteins to the 
membrane.  However, cells that expressed GFP-GAP-CTK (Figure 3.7) or GFP-
GAP-CTH (Figure 3.8) specifically inhibited endogenous GTP-loaded K-Ras or H-
Ras, respectively.  Significant inhibition was observed at the early times assayed (2-
10min).  Neither construct had an inhibitory effect on the Ras isoform that was not  
 
Figure 3.6. Cytosolic GAP Does Not Inhibit Ras Activation.  BHK cells 
transiently expressing GFP (Empty Vector) and GFP-Cytosolic GAP proteins were 
serum starved for 1 hr. and stimulated with 50ng/ml EGF for time points up to 60 
min.  A) GTP-loaded Ras proteins were isolated by GST-RBD pull-down and 
detected by immunoblot using pan-Ras antibody.   Whole cell lysates (WCL) were 
imunoblotted using pan-Ras antibody for protein input.  B) Blots were quantified and 
the graph show the levels of GTP-Ras at each time point normalized to GFP time 
point 0 (means ± SEM, n=3) 
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Figure 3.7. GFP-GAP-CTK abrogates endogenous K-Ras Activation.  BHK cells 
transiently expressing GFP (Empty Vector) and GFP-GAP-CTK proteins were 
serum starved for 1 hr. and stimulated with 50 ng/ml EGF for time points up to 60 
min.  A) C) GTP-loaded Ras proteins were isolated by GST-RBD pull-down and 
detected by immunoblot using H-Ras or K-Ras antibody.  Whole cell lysates (WCL) 
were imunoblotted using pan-Ras antibody for protein input.  B) D) Blots were 
quantified and the graph shows the levels of GTP-Ras at each time point 
normalized to GFP time point 0 (means ± SEM, n=4) 
 
 
 
 
 
 
*** 
*** 
*** 
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Figure 3.8. GFP-GAP-CTH abrogates endogenous H-Ras Activation.  BHK cells 
transiently expressing GFP (Empty Vector) and GFP-GAP-CTH proteins were 
serum starved for 1 hr. and stimulated with 50 ng/ml EGF for time points up to 60 
min.  A) C) GTP-loaded Ras isoforms were isolated by GST-RBD pull-down and 
detected by immunoblot using H-Ras or K-Ras antibody.  Whole cell lysates (WCL) 
were imunoblotted using pan-Ras antibody for protein input.  B) D) Blots were 
quantified and the graph shows the levels of GTP-Ras at each time point 
normalized to GFP time point 0 (means ± SEM, n=4) 
 
 
 
 
 
 
** 
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Figure 3.9. GFP-GAP-CTH181S Effects on Ras Activation.  BHK cells transiently 
expressing GFP (Empty Vector) and GFP-GAP-CTH181S proteins were serum 
starved for 1 hr. and stimulated with 50 ng/ml EGF for time points up to 60 min.  A) 
C) GTP-loaded Ras isoforms were isolated by GST-RBD pull-down and detected by 
immunoblot using H-Ras or K-Ras antibody.  Whole cell lysates (WCL) were 
imunoblotted using pan-Ras antibody for protein input.  B) D) Blots were quantified 
and the graph shows the levels of GTP-Ras at each time point normalized to GFP 
time point 0 (means ± SEM, n=4) 
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associated with its targeted domain. Therefore, GFP-GAP-CTK had no effect on 
H-Ras activation, and GFP-GAP-CTH had no effect on K-Ras activation.  
Unexpectedly, we did not detect any effect of the Golgi localized GFP-RasGAP 
protein, GFP-GAP-CTH181S, on Ras activation.  As depicted in Figure 3.9, there 
are relatively low levels of GTP-Ras at the late time points (20-60 min) when Golgi 
Ras activation is maximal.  Our method may, therefore, not be sufficiently sensitive 
to detect changes in this low level of Ras activation.  However, there was no 
abrogation at the earlier times (2-10min) by GFP-GAP-CTH181S where Ras is 
maximally activated.  Since Ras activation on the plasma membrane has been 
previously shown to occur between 2-10min following EGF stimulation, we can 
conclude that very little GFP-GAP-CTH181S has access to GTP-Ras generated on 
the plasma membrane. 
3.2.3 GFP-RasGAP Proteins Specifically Inhibit Ras Isoforms on the PM and Golgi 
In an effort to resolve the sensitivity issue of the GST-RBD pull-down assay 
and verify the ability of the targeted GAP proteins to specifically abrogate activation 
of  Ras isoforms in distinct sub-cellular compartments we used confocal 
microscopy.  The Ras binding domain (RBD) C-Raf (amino acids 51-131) has been 
previously used  in imaging studies to report where and when Ras is active in cells 
(Walker and Lockyer, 2004).  We therefore generated an RFP-RBD fusion protein 
by cloning RFP onto the N- terminus of the RBD.  We then tested the ability of this 
fluorescent probe (RFP-RBD) to detect Ras activation on the plasma membrane 
and Golgi in fixed cells.  As shown in Figure 3.10, expression of RFP-RBD alone in 
Cos-1 cells resulted in a homogenous localization to the cytosol and nucleoplasm 
with no evidence of membrane decoration.  However, in the presence of a 
constitutively active form of 
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Figure 3.10. RFP-RBD Detects GTP-Loaded Ras on the Plasma Membrane and 
the Golgi.  Cos-1 cells were transiently transfected with RFP-RBD or RFP-RBD 
and GFP-HrasG12V.  Cells were fixed on glass coverslips and visualized by 
fluorescence microscopy. 
 
H-Ras, H-RasG12V, the RFP-RBD probe was recruited to both the plasma 
membrane and Golgi, co- localizing exclusively with active H-Ras.  Next, RFP-RBD 
was transiently co- expressed with GFP-RasGAP proteins in the presence or 
absence of wild-type H- Ras or K-Ras.  Cells were deprived of serum prior to 
stimulation with EGF for 2min in order to observe maximal EGF-induced Ras 
activation on the plasma membrane.  The extent of RFP-RBD localization to the 
plasma membrane was quantified using Image J software and the fraction of RFP-
RBD recruitment to the plasma membrane was calculated (Figure 3.11).  As shown 
in Figure 3.12, in response to EGF stimulation, most of RFP-RBD is localized to the 
cytosol.  When RFP-RBD was co-expressed with H-Ras or K-Ras, a dramatic 
redistribution of RFP-RBD from the cytosol to the plasma membrane was observed 
upon EGF stimulation.  In cells expressing wild-type K-Ras, the presence of GFP-
GAP-CTK significantly reduced recruitment of RFP-RBD to the plasma membrane.   
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Figure 3.11. Quantification of RFP-RBD Localization to the Plasma Membrane.  
In GFP-RasGAP expressing cells, the extent of RFP-RBD localization to the plasma 
membrane (PM) was determined via quantification by Image J software.  A line 
scan was drawn manually across individual healthy cells for quantification of RFP-
RBD localization.  The output generated is a plot of the intensity values of RFP-RBD  
From the plot, areas representing RFP-RBD intensity on the PM or the cytosol 
(CYT) were identified and gated as shown.  RFP-RBD intensity values for the PM 
were integrated and the average determined.  RFP-RBD intensity values for the 
CYT were also averaged.  The percentage of PM-recruited RFP-RBD, was 
calculated by a ratio of the average RFP-RBD intensity values      on the PM and 
the sum of the averages of RFP-RBD intensity values on the PM and the CYT.  This 
was done for each cell.   
 
 
Figure 3.12. GFP-RasGAP Proteins Abrogate Ras Activation on the Plasma 
Membrane. Cos-1 cells were transiently transfected with GFP-RasGAP proteins 
and/or RFP-RBD in the presence or absence of wild-type Ras.  Cells were serum 
starved and stimulated with 50 ng/ml EGF for 2min and subsequently fixed and 
visualized by fluorescence microscopy.  The average RFP-RBD intensity on the 
plasma membrane was determined by Image J software.  A)The graph represents 3 
individual experiments with means ± SEM, n=100. B) Respresentative blots 
demonstrating the expression of each construct. 
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GFP-GAP-CTK did not affect H-Ras mediated recruitment of RFP-RBD to the 
plasma membrane.  Similarly, GFP-GAP-CTH expression abrogated recruitment of 
RFP-RBD to the plasma membrane in cells expressing H-Ras, but not K-Ras.  To 
observe Ras activation on the Golgi, we co-expressed RFP-RBD with CFP-H-Ras 
and GFP-RasGAP proteins and imaged cells after 40min of EGF stimulation.  
Expression of CFP-H-Ras permits visualization of Ras on the Golgi. The extent of 
RFP-RBD localization to the Golgi was determined only from cells where Golgi 
staining by CFP-H-Ras was evident using Image J software. Hereafter, we 
assessed the fraction of RFP-RBD recruitment to the Golgi (Figure 3.13).   
Figure 3.13. Quantification of RFP-RBD Localization to the Golgi.  In GFP-
RasGAP expressing cells, the extent of RFP-RBD localization to the Golgi was 
determined via quantification by Image J software.  A line scan was drawn manually 
across individual healthy cells for quantification of RFP-RBD or CFP-H-Ras 
localization.  The output generated is a plot of the intensity values of RFP-RBD or 
CFP-H-Ras.  From the CFP-H-Ras line scan, the Golgi was identified.  Then, the 
areas representing CFP-H-Ras intensity on the Golgi were identified and gated.  
These marked boundaries were also used to identify and gate RFP-RBD 
recruitment to the Golgi on the RFP-RBD plot.  CFP-H-Ras and RFP-RBD intensity  
 intensityvalues for the Golgi were averaged.  A ratio of Golgi-recruited RFP-RBD 
and Golgi-recruited CFP-H-Ras was determined.  This was done for each cell. 
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As shown in Figure 3.14, a significant portion of RFP-RBD accumulation on the 
Golgi is clearly visible after 40 min. of EGF stimulation when wild-type H-Ras is 
expressed.  Figure 3.15 shows that GFP-GAP-CTH did not affect the recruitment of 
RFP-RBD to the Golgi; however, GFP-GAP-CTH181S expression caused 
significant reduction of RFP-RBD localization to the Golgi.  These data support the 
 
Figure 3.14.  RFP-RBD Colocalizes with CFP-H-Ras. Cos-1 cells were transiently 
transfected with RFP-RBD or RFP-RBD and CFP-Hras WT and stimulated with 50 
ng/ml EGF for 40 min.  Immediately following stimulation, cells were fixed on glass 
coverslips and visualized by fluorescence microscopy. 
 
previous findings that all 3 GFP-RasGAP targeted proteins specifically abrogate 
activation of specific Ras isoforms, which occurs on the plasma membrane and the 
Golgi.  
 3.2.4 Effects of GFP-RasGAP Proteins on Ras Signal Transduction 
 In order to investigate the ability of GFP-RasGAP proteins to abrogate Ras 
signal transduction, we assayed the effects of GFP-RasGAP on the MAPK and PI-
3K/Akt signaling pathways. GFP-RasGAP proteins were transiently expressed in 
BHK cells that were serum starved and stimulated with EGF for various times  
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Figure 3.15. GFP-GAP-CTH181S Abrogates Ras Activation on the Golgi.  Cos-1 
cells were transiently transfected with GFP-RasGAP proteins and/or RFP-RBD in 
the presence or absence of CFP-H-Ras.  Cells were serum starved for 1 hr. and 
stimulated with 50ng/ml EGF for 40min and subsequently fixed and visualized by 
fluorescence microscopy.  The average RFP-RBD intensity on the Golgi was 
determined by Image J software.  A) The graph represents 3 individual experiments 
with means ± SEM, n=100.  B) Respresentative blots demonstrating the expression 
of each construct. 
 
immunoblotting whole cell lystates using antiserum against ppERK and pAkt.  As 
seen in Figure 3.16, maximal ERK activation occurs at 10min of growth factor 
stimulation and subsequently reduces, but does not return to basal levels on the 
time cap of this experiment.  Figure 3.16 shows that GAP-CTK significantly 
decreased the level of ppERK when ERK was maximally activated (10min).  GFP-
GAP-CTH had no significant effect on the level of EGF-stimulated ppERK compared 
to the control cells (Empty Vector).  Similarly, GFP-GAP-CTH181S did not alter the 
ERK activation profile.  EGF-induced activation of Akt differs from ERK activation.  
Figure 3.17 shows that the activation profile of Akt has two peaks, one at 5min and 
the other at 40min following growth factor stimulation.  Intriguingly, GFP-GAP-
CTH181S significantly increased Akt activation at 5min; however GFP-GAP-CTH 
and GFP-GAP-CTK had no effect on the activation profile of Akt.  Since ERK  
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Figure 3.16. EGF stimulation of the MAPK pathway is significantly inhibited by 
GFP-GAP-CTK.  BHK cells transiently expressing GFP (Empty Vector) and A) 
GFP-GAP-CTH, B) GFP-GAP-CTK, and C) GFP-GAP-CTH181S were serum 
starved for 1 hr. and stimulated with 50 ng/ml EGF for times up to 60 min.  Whole 
cell lysates were analyzd by immunoblotting with a ppERK antibody or pan-ERK.  
Blots were quantified and the graph shows the levels of ppERK at each time point 
normalized to GFP time point 0 (means ± SEM, n≥7). 
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Figure 3.17. GFP-RasGAP Proteins Effect on the Akt Pathway. BHK cells 
transiently expressing GFP (Empty Vector) and A) GFP-GAP-CTH, B) GFP-GAP-
CTK, and C) GFP-GAP-CTH181S were serum starved for 1hr. and stimulated with 
50 ng/ml EGF for times up to 60 min.  Whole cell lysates were analyzed by 
immunoblotting with a pAKt473 antibody or pan-Akt.  Blots were quantified and the 
graphs show the levels of pAkt473 at each time point normalized to GFP time point 
0 (means ± SEM, n≥9). 
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activation is exclusively inhibited by GFP-GAP-CTK, we can conclude that EGF 
stimulation of the Raf/MEK/ERK pathway is predominantly mediated by K-Ras, 
whereas activation of thePI3-K/Akt pathway appears largely Ras independent.  
3.2.5 Effects of GFP-RasGAP Proteins on Ras-Dependent Biological 
 
 Next, we examined the biological consequences of inhibiting endogenous 
Ras signaling by assaying cellular proliferation and differentiation.  First, we 
assayed cellular growth and viability via flow cytometry.  BHK cells transiently 
transfected with GFP-RasGAP constructs were grown in culture over a period of 4 
days and the number of GFP expressing cells in a total cell population of 10,000 
cells was quantified each day using flow cytometry.  As a control, we used GFP 
tagged to the minimal targeting motif of H-Ras, GFP-tH.  GFP-tH has been 
characterized as a plasma membrane marker.  In this assay, if the expression of 
GFP-RasGAP proteins inhibits cellular growth, proliferation, or viability, the number 
of GFP positive cells will decrease while non-transfected cells continue to grow and 
eventually take over the cell population.  As demonstrated in Figure 3.18, 
expression of GFP-tH had no significant effect on the fraction of GFP-expressing 
cells present throughout the 4 day period indicating that expression of GFP-tH does 
not compromise cellular growth or viability.  However, expression of GFP-RasGAP 
proteins resulted in a significant decrease in the number of GFP positive cells 
during the time assayed.   GFP-GAP-CTK and GFP-GAP-CTH were equipotent 
inhibitors of cellular growth and viability, whereas GFP-GAP-CTH181S was less 
potent.  Next, we examined the effect of GFP-RasGAP protein expression on 
cellular differentiation using a PC-12 differentiation assay.  Rat adrenal 
pheochromocytoma (PC-12) cells are widely utilized as a model system for 
neuronal differentiation since they stop dividing and terminally differentiate in 
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response to nerve growth factor (NGF) (Santos et al., 2007).  Figure 3.19 shows an 
undifferentiated PC-12 cell and an example of a differentiated PC-12 cell.  In this 
section of the study, we transiently transfected PC-12 cells with or without  
 
Figure 3.18. Effects of GFP-RasGAP Proteins on Cellular Proliferation.  BHK 
cells were transiently transfected with GFP-tH, GFP-GAP-CTH, GFP-GAP-CTK, or 
GFP-GAP-CTH181S in triplicates.  The number of GFP-positive cells was quantified 
each day by a flow cytometer over a period of 4 days.  The graph shows the relative 
number of GFP-positive cells for the indicated constructs normalized to Day 1 of 
GFP-tH (means ± SEM, n=3). 
 
GFP-RasGAP proteins and stimulated these cells with 100 ng/mL NGF.  Then, we 
imaged and counted undifferentiated and differentiated transfected cells.  Cells with 
neurite outgrowths equal to or more than twice the size of the cell body were 
counted as differentiated, while cells with shorter or no neurite outgrowths were 
considered undifferentiated.  Expression of GFP-RasGAP proteins significantly 
decreased differentiation of PC-12 cells (Figure 3.18).  Specifically, GFP-GAP-CTK 
and GFP-GAP-CTH suppressed differentiation with similar potency, while GFP-
GAP-CTH181S suppressed differentiation with greater efficiency than GFP-GAP-
CTK and GFP-GAP-CTH.  Since differentiation of PC-12 cells is greatly attenuated 
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by the expression of GAP targeted to the Golgi (GFP-GAP-CTH181S), we can 
conclude that Ras activation on the Golgi is a major driver of cellular differentiation.  
On the contrary, GFP-GAP-CTK and GFP-GAP-CTH, but not GFP-GAP-CTH181S, 
are more potent attenuators of cellular growth of BHK cells; thus Ras activation on 
the plasma membrane is the major driver of cellular proliferation. 
  
 
Figure 3.19. Effects of GFP-RasGAP Proteins on Cellular Differentiation.  PC-
12 cells were transiently transfected with GFP (Empty Vector), GFP-GAP-CTH, 
GFP-GAP-CTK, or GFP-GAP-CTH181S and assayed for differentiation after 72 hrs 
of stimulation by NGF.  A) The graph shows the mean (± SEM, n=100) percentage 
of transfected, GFP-positive cells with neurite outgrowths equal to or more than 
twice the size of the cell body. Data represents 3 individual experiments. B) 
Representative images of differentiated and undifferentiated cells counted. 
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Chapter 4.  Discussion 
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4.1 Introduction 
 There is clear evidence that Ras proteins can be activated on multiple 
cellular compartments in addition to the plasma membrane.  The significance of Ras 
signaling from the endomembrane, however, is unclear.  To address this, we 
constructed Ras isoform-specific inhibitors, GFP-RasGAP fusion proteins, targeted 
to distinct plasma membrane nanodomains and the Golgi.  We found that each 
GFP-RasGAP protein specifically abrogates the targeted endogenous Ras isoform 
on the plasma membrane and Golgi.  We observed striking differences in the ability 
of GFP-RasGAP proteins to inhibit Ras signal transduction.  Furthermore, we found 
that the expression of GFP-RasGAP proteins significantly and differentially altered 
the biological output of Ras signaling. 
4.2 Role of Endogenous Ras Signaling 
By abrogating the activity of an individual, endogenous Ras isoform with the 
corresponding GFP-RasGAP protein, novel insight into the organization of 
endogenous Ras proteins on the nanoscale level was discovered.  We 
demonstrated that endogenous GTP-bound H-Ras and K-Ras occupy distinct 
plasma membrane nanodomains.  This supports previous data which used 
ectopically expressed Ras proteins to show differential nano-localization of each 
Ras isoform on the plasma membrane (Murakoshi et al., 2004; Plowman et al., 
2005; Prior et al., 2003; Roy et al., 2005).   
Since one function of Ras nanoclusters in Ras signaling is to recruit C-Raf to 
the plasma membrane for subsequent activation (Harding and Hancock, 2008a; 
Harding and Hancock, 2008b; Tian et al., 2007), we were able to investigate the 
role of endogenous Ras proteins in C-Raf activation in plasma membrane 
nanodomains.  We demonstrated that GFP-RasGAP targeted by the HVR of K-Ras 
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but not the HVR of H-Ras significantly attenuated the levels of activated ERK in 
response to stimulation by EGF.  We conclude that endogenous K-Ras is the 
predominant mediator of EGF-induced activation of ERK, whereas H-Ras has no 
significant role in ERK activation in response to EGF.  These results support earlier 
studies that demonstrated that C-Raf is more potently activated by K-Ras than any 
other Ras isoform.  These earlier studies used ectopic expression of an oncogenic 
form of the Ras isoform to determine the efficacy of Ras isoform-specific mediated 
C-Raf activation (Yan et al., 1998).  Our new results now show that endogenous K-
Ras is also a more potent activator of Raf/MEK/ERK pathway than H-Ras. We also 
assayed another important Ras signaling pathway, PI3-K/Akt pathway.  Previous 
studies have shown that the ectopically expressed constitutively active form of H-
Ras is a potent activator of the PI3-K/Akt pathway (Yan et al., 1998).  However, our 
data here show that neither GFP-GAP-CTH nor GFP-GAP-CTK expression 
significantly inhibited Akt activation.  Unlike ERK activation, which is K-Ras 
dependent, activation of Akt may be mediated by both K-Ras and H-Ras and/or N-
Ras which we did not investigate.  Therefore, preventing activation of a single Ras 
isoform, with either GFP-GAP-CTH or GFP-GAP-CTK, still allows other Ras 
isoforms to activate PI3-K/Akt.  Moreover, PI3-K can also be activated directly by 
the EGF receptor.  Our results could also indicate that PI3-K activation on the 
plasma membrane, at low doses of EGF, is largely Ras-independent.  One 
approach to test this hypothesis would be to express each GFP-RasGAP protein in 
EGF receptor null cells, stimulate with growth factor, and assess phosphorylated 
Akt levels.  This will allow us to determine whether or not PI3-K activation is solely 
dependent upon activation of the EGF receptor. 
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Perhaps, the most intriguing result yet was the observation of significantly 
increased levels of phosphorylated Akt levels at 5 min. in EGF-stimulated cells that 
express GFP-GAP-CTH181S.  This data suggests that Akt activation is increased 
on the plasma membrane when Ras activation on the Golgi is abrogated.  An 
explanation for this result may be possible competition of PI3-K regulatory and 
catalytic subunits for recruitment to the plasma membrane or Golgi.  Activation of 
PI3-K occurs through at least two independent mechanisms:  binding of the catalytic 
subunit of PI3-K, p110, to GTP-loaded Ras and binding of the regulatory subunit of 
PI3-K, p85, to an activated receptor tyrosine kinase (RTK) which stimulates p110 
activation (Krasilnikov, 2000).  By blocking Ras activation on the Golgi, it is possible 
that the translocation of PI3-K (p110/p85) is enhanced for direct activation by the 
EGF receptor.  In turn higher levels of PI3-K activation on the plasma membrane 
leads to an increase in the levels of phosphorylated Akt.  Another potential 
explanation could be a reduction in the plasma membrane accumulation of 
phosphatases in response to abrogation of Ras-GTP on the Golgi.  Phosphatases 
such as PTEN, SHIP1, and SHIP2 can prevent the activation of Akt (Vivanco and 
Sawyers, 2002); but, how RasGTP on the Golgi might regulate plasma membrane 
delivery of such phosphatases is unclear. 
4.3 Regulation of Endogenous Ras Activation 
As previously reported, Ras activation mediated by the EGF receptor occurs 
rapidly (Murakoshi et al., 2004; Zhao et al., 2007).  Immediately following EGF 
stimulation, we observed Ras GTP-loading that endured until 20min before 
returning to basal levels with maximum Ras activation by 2 min.  Since RasGEFS 
are responsible for the exchange of RasGDP for RasGTP (Bernards and Settleman, 
2007), this data suggests that endogenous RasGEFs are rapidly recruited to the 
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plasma membrane in response to activation of the EGF receptor.  The subsequent 
return of Ras activation to basal levels is a potential consequence of an up-
regulation of endogenous RasGAP activity as well as a down-regulation of 
endogenous RasGEF activity.  In support of these results, earlier studies have 
demonstrated an up-regulation of RasGAP activity dependent upon activated 
growth factor receptors.  For instance, upon binding of EGF, EGF receptors recruit 
PLCγ which leads to the generation of DAG and InsP3 through the hydrolysis of 
PIP2.  This stimulates calcium release causing an increase or up-regulation in the 
recruitment of the RasGAP CAPRI to the plasma membrane.  Like CAPRI, the 
RasGAP GAP1m is recruited to the plasma membrane due to production of PIP3 
from the RasGTP-dependent activation of PI3-K (Lockyer et al., 2001; Lockyer et 
al., 1999).  p120RasGAP also binds to phosphorylated tyrosine sites of activated 
platelet derived growth factor (PDGF) and EGF receptors (Kaplan et al., 1990; 
Kazlauskas and Cooper, 1990; Soler et al., 1993).  Our results generally support 
these concepts that p120RasGAP mediated GTP hydrolysis of Ras requires 
membrane recruitment.  Specifically, we show that the expression of cytosolic GFP-
GAP does not alter endogenous RasGTP levels on the plasma membrane. 
Recent reports have suggested that release of palmitoylated Ras isoforms 
from the plasma membrane to the Golgi, due to a continuous depalmitoylation/re-
palmitoylation cycle, is required for EGF-induced Ras activation at the Golgi.  
However, our results suggest that retrograde trafficking of Ras from the plasma 
membrane to the Golgi does not account for the prolonged (EGF stimulation for 
40min) accumulation of RFP-RBD on the Golgi.  Targeting GAP by the HVR of H-
Ras (GFP-GAP-CTH) to the plasma membrane significantly decreased the 
accumulation of RFP-RBD on the plasma membrane but had no affect on RFP-RBD 
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localization to the Golgi; yet, we were able to reduce RFP-RBD accumulation on the 
Golgi by targeting GAP to the Golgi (GFP-GAP-CTH181S).  These results suggest 
that Ras activation on the Golgi is independent of the 
depalmitoylation/repalmitoylation cycle and may occur directly at the Golgi.  These 
results support a previous study where GFP-RBD was utilized to report Ras 
activation on the Golgi and the dependence of Ras activation at this compartment 
on Src.  In T cells, a pathway for Ras activation on the Golgi involving the Src-
dependent activation of phospholipase C-γ1 (PLC-γ1) has been proposed.  This 
pathway includes the translocation of the RasGEF RasGRP1 from the cytosol to the 
Golgi where it activates Ras. 
4.4 Biological Consequences of Endogenous Ras Signaling 
Next, we investigated the ability of RasGAP proteins to modify cellular 
growth.  The expression of each RasGAP protein impeded cellular growth; however, 
with varying efficiency.   RasGAP proteins targeted to endogenous H-Ras and K-
Ras nanoclusters (GFP-GAP-CTH and GFP-GAP-CTK) on the plasma membrane 
significantly suppressed cellular growth with similar efficacy.  RasGAP targeted to 
H-Ras on the Golgi (GFP-GAP-CTH181S) suppressed cellular growth to a lesser 
extent than GFP-GAP-CTH and GFP-GAP-CTK.  Therefore, we conclude that 
activation of endogenous H-Ras and K-Ras on the plasma membrane is more 
important for growth than Ras activation on the Golgi.  Correlating these effects on 
cellular growth with MAPK activation alone is difficult since only GFP-GAP-CTK 
significantly reduced ERK activation, yet all 3 GFP-RasGAP constructs inhibited 
growth to a greater or lesser extent.   It seems most probable that other Ras 
effectors, which we did not assay, are required for cellular proliferation.   
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Differential regulation of cellular proliferation by distinct pools of Ras 
activation has been previously described.  Palmitoylation-deficient constitutively 
active H-Ras targeted to bulk membrane or lipid rafts of the plasma membrane 
similarly enhances cellular proliferation.  In contrast, targeting this protein to the 
Golgi with a KDEL receptor mutant (KDELr N193D) which traps the protein in the 
Golgi does not enhance growth, but can sustain limited cellular growth.  
Interestingly, our results support this report providing evidence of differential affects 
of endogenous Ras activation at the plasma membrane and the Golgi on cellular 
proliferation.   
We also examined whether the expression of RasGAP proteins would alter 
the cellular fate of PC12 cells.  We showed that the expression of GFP-RasGAP 
proteins significantly reduced the levels of differentiation in PC12 cells.  Specifically, 
GFP-GAP-CTH and GFP-GAP-CTK suppress cellular differentiation with similar 
efficacy while GFP-GAP-CTH181S expression results in the most profound 
suppression of PC12 differentiation.  In striking contrast to cellular growth, we can 
conclude that the activation of endogenous Ras on the Golgi is more important for 
cellular differentiation than H- or K-Ras on the plasma membrane.  Our results of 
endogenous plasma membrane-localized Ras contrast with a previous study where 
abrogation of endogenous Ras activation on the plasma membrane had no 
inhibitory affect on cellular differentiation.  However, differences in specificity may 
likely account for this discrepancy.  We targeted the GAP catalytic domain of 
p120RasGAP to specific Ras nanoclusters on the plasma membrane to assess 
regulation of differentiation by H-Ras or K-Ras, whereas the aforementioned study 
overexpressed the RasGAP CAPRI and failed to target the protein to specific sites 
of Ras activation on the plasma membrane.  Consequently, all Ras isoforms are 
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subject to inhibition by CAPRI and the effects on individual Ras isoforms are 
ignored.  Furthermore, oncogenic H-Ras tethered to the Golgi is sufficient to 
enhance cellular differentiation.  Using a different approach, we confirm that 
endogenous H-ras activation on the Golgi has a key role in cellular differentiation. 
PC12 cells are established as a model system for signal specificity of the 
MAPK pathway.  Upon stimulation by NGF, the MAPK pathway (Raf/MEK/ERK) is 
activated through the receptor tyrosine kinase TrkA giving rise to cellular 
differentiation.  The MAPK pathway is also activated by EGF through the EGF 
receptor which leads to cellular proliferation.  How the MAPK network processes 
these different inputs into specific biological outputs in PC12 cells has been studied.   
The underlying cause for these opposite cellular fates (proliferation and 
differentiation) is the differences in the dynamics of ERK activation.  EGF 
stimulation of the MAPK pathway prompts transient ERK activation where as NGF 
stimulation produces sustained ERK activation (Marshall, 1995).  A proposed model 
further explains the molecular interpretation of distinct ERK dynamics by immediate 
early gene products (IEGs).  When ERK activation is sustained, IEGs are stabilized 
by ERK-catalyzed phosphorylation.  Consequently, different genes dependent upon 
sustained ERK activity are expressed (Murphy et al., 2002).  Furthermore, it is 
believed that upstream of ERK acitivity lies a distinct set of positive and negative 
regulators which are differentially activated by EGF and TrkA receptors, thereby 
contributing to opposite cellular fates.  Among these regulators are PKC and Raf 
kinase inhibitory protein (RKIP), respectively (Santos et al., 2007).  Interestingly, 
abrogation of RasGTP on the Golgi significantly decreased differentiation revealing 
that Ras activity on the Golgi is important for differentiation than RasGTP on the 
plasma membrane.  Since RasGTP on the Golgi has been characterized by 
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sustained Ras activation (Chiu et al., 2002), it seems likely that sustained Ras 
activity on the Golgi is responsible for sustained ERK activity and therefore cellular 
differentiation observed in PC12 cells.  As for cellular proliferation, however, 
precisely which Ras signaling pathways are responsible is not clear from our work.  
Finally, our work has focused on H-Ras and K-Ras.  It would be interesting to 
examine the effects of RasGAP on N-Ras activity.  To accomplish this, we would 
simply target the catalytic domain of p120RasGAP to nanodomains that occupy 
GTP-loaded N-Ras.  This can be done by fusing the HVR of N-Ras to the catalytic 
domain of p120RasGAP.  Generally, in plasma membrane localization studies, N-
Ras has not been extensively studied, so less is known about the N-Ras 
nanoclustering. Both H-Ras and N-Ras have been shown to signal from the Golgi.  
A comparison study between these two Ras isoforms using GFP-RasGAP proteins 
targeted to the Golgi would be interesting. 
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